<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:92.6pt;left:60.7pt;line-height:13.0pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:13.0pt;color:#ffffff">REVIEW</span></p>
<p style="top:92.6pt;left:461.4pt;line-height:13.0pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:13.0pt;color:#ffffff">Open Access</span></p>
<p style="top:122.3pt;left:56.7pt;line-height:23.4pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:23.4pt">The effects of exercise on cognition in Parkinson</span><span style="font-family:BdwjnbAdvTTe45e47d2+20,serif;font-size:23.4pt">&#x2019;</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:23.4pt">s</span></p>
<p style="top:148.3pt;left:56.7pt;line-height:23.4pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:23.4pt">disease: a systematic review</span></p>
<p style="top:182.4pt;left:56.7pt;line-height:10.7pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.7pt">Danielle K Murray</span><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.6pt">1*</span></sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.7pt">, Matthew A Sacheli</span><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.6pt">1</span></sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.7pt">, Janice J Eng</span><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.6pt">2</span></sup><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.7pt"> </span></sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.7pt">and A Jon Stoessl</span><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.6pt">1</span></sup></p>
<p style="top:221.3pt;left:63.2pt;line-height:10.3pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:10.3pt">Abstract</span></p>
<p style="top:239.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">Cognitive impairments are highly prevalent in Parkinson</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:10.0pt">&#x2019;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">s disease (PD) and can substantially affect a patient</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:10.0pt">&#x2019;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">s quality</span></p>
<p style="top:251.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">of life. These impairments remain difficult to manage with current clinical therapies, but exercise has been identified</span></p>
<p style="top:263.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">as a possible treatment. The objective of this systematic review was to accumulate and analyze evidence for the</span></p>
<p style="top:275.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">effects of exercise on cognition in both animal models of PD and human disease. This systematic review was</span></p>
<p style="top:287.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement.</span></p>
<p style="top:299.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">Fourteen original reports were identified, including six pre-clinical animal studies and eight human clinical studies.</span></p>
<p style="top:311.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">These studies used various exercise interventions and evaluated many different outcome measures; therefore, only a</span></p>
<p style="top:323.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">qualitative synthesis was performed. The evidence from animal studies supports the role of exercise to improve</span></p>
<p style="top:335.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">cognition in humans through the promotion of neuronal proliferation, neuroprotection and neurogenesis. These</span></p>
<p style="top:347.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">findings warrant more research to determine what roles these neural mechanisms play in clinical populations.</span></p>
<p style="top:359.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">The reports on cognitive changes in clinical studies demonstrate that a range of exercise programs can improve</span></p>
<p style="top:371.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">cognition in humans. While each clinical study demonstrated improvements in a marker of cognition, there</span></p>
<p style="top:383.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">were limitations in each study, including non-randomized designs and risk of bias. The Grading of Recommendations</span></p>
<p style="top:395.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">Assessment, Development and Evaluation (GRADE) system was used and the quality of the evidence for human studies</span></p>
<p style="top:407.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">were rated from</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:10.0pt"> &#x201c;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">low</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:10.0pt">&#x201d;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt"> to</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:10.0pt"> &#x201c;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">moderate</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:10.0pt">&#x201d;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt"> and the strength of the recommendations were rated from</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:10.0pt"> &#x201c;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">weak</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:10.0pt">&#x201d;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt"> to</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:10.0pt"> &#x201c;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">strong</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:10.0pt">&#x201d;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">.</span></p>
<p style="top:419.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">Studies that assessed executive function, compared to general cognitive abilities, received a higher GRADE rating.</span></p>
<p style="top:431.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">Overall, this systematic review found that in animal models exercise results in behavioral and corresponding</span></p>
<p style="top:443.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">neurobiological changes in the basal ganglia related to cognition. The clinical studies showed that various types</span></p>
<p style="top:455.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">of exercise, including aerobic, resistance and dance can improve cognitive function, although the optimal type,</span></p>
<p style="top:467.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">amount, mechanisms, and duration of exercise are unclear. With growing support for exercise to improve not</span></p>
<p style="top:479.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">only motor symptoms, but also cognitive impairments in PD, health care providers and policy makers should</span></p>
<p style="top:491.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">recommend exercise as part of routine management and neurorehabilitation for this disorder.</span></p>
<p style="top:508.5pt;left:63.2pt;line-height:10.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:10.0pt">Keywords:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt"> Parkinson</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:10.0pt">&#x2019;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:10.0pt">s disease, Exercise, Cognition, Humans, Animals</span></p>
<p style="top:538.7pt;left:56.7pt;line-height:10.3pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:10.3pt">Introduction</span></p>
<p style="top:551.6pt;left:56.7pt;line-height:9.2pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:9.2pt">Rationale and objective</span></p>
<p style="top:563.1pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Aside from well-documented motor symptoms, most</span></p>
<p style="top:575.1pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Parkinson</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x2019;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">s disease (PD) patients suffer from associated</span></p>
<p style="top:587.1pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">non-motor complications, including cognitive impair-</span></p>
<p style="top:599.1pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ment, mood disorders, olfactory dysfunction, sleep dis-</span></p>
<p style="top:611.1pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">turbance, fatigue and anxiety [1-3]. Of the non-motor</span></p>
<p style="top:623.1pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">symptoms, cognitive impairments are particularly preva-</span></p>
<p style="top:635.1pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">lent in PD with up to 83% of patients developing</span></p>
<p style="top:539.1pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">dementia after 20 years [4]. The non-motor symptoms</span></p>
<p style="top:551.1pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">of PD can be at least as detrimental as motor manifesta-</span></p>
<p style="top:563.1pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tions for a patient</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x2019;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">s health and overall quality of life, but</span></p>
<p style="top:575.1pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">unfortunately remain difficult to manage with current</span></p>
<p style="top:587.1pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">clinical therapies [1-3].</span></p>
<p style="top:599.1pt;left:312.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">The current gold-standard for testing global cognitive</span></p>
<p style="top:611.1pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">capacity in clinical practice includes objective verbal and</span></p>
<p style="top:623.1pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">written tests. Of the quick screening cognitive tests</span></p>
<p style="top:635.1pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">available, the Montreal Cognitive Assessment (MoCA)</span></p>
<p style="top:647.1pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">[5] has been widely accepted for use in PD populations</span></p>
<p style="top:659.1pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">[6] by assessing multiple domains of cognitive function</span></p>
<p style="top:671.1pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">including memory, language, complex visuospatial pro-</span></p>
<p style="top:683.1pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cessing, and executive function. This validated tool has</span></p>
<p style="top:657.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">* Correspondence:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt"> danielle.k.murray@gmail.com</span></p>
<p style="top:665.2pt;left:56.7pt;line-height:5.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:5.3pt">1</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Pacific Parkinson</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.5pt">&#x2019;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">s Research Centre and Department of Medicine, Division of</span></p>
<p style="top:675.7pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Neurology, University of British Columbia &amp; Vancouver Coastal Health,</span></p>
<p style="top:684.7pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Vancouver, BC V6T 2B5, Canada</span></p>
<p style="top:693.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Full list of author information is available at the end of the article</span></p>
<p style="top:40.1pt;left:423.9pt;line-height:12.5pt"><b><span style="font-family:LnbrjtFrutigerLTStd,serif;font-size:12.5pt;color:#25265e">Translational </span></b></p>
<p style="top:55.2pt;left:423.9pt;line-height:12.5pt"><b><span style="font-family:LnbrjtFrutigerLTStd,serif;font-size:12.5pt;color:#25265e">Neurodegeneration</span></b></p>
<p style="top:711.3pt;left:180.5pt;line-height:6.8pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:6.8pt">&#xa9; 2014 Murray et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative</span></p>
<p style="top:719.2pt;left:180.5pt;line-height:6.8pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:6.8pt">Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and</span></p>
<p style="top:727.2pt;left:180.5pt;line-height:6.8pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:6.8pt">reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain</span></p>
<p style="top:735.2pt;left:180.5pt;line-height:6.8pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:6.8pt">Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,</span></p>
<p style="top:743.2pt;left:180.5pt;line-height:6.8pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:6.8pt">unless otherwise stated.</span></p>
<p style="top:34.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Murray</span><span style="font-family:QcghtbAdvTT7329fd89.I,serif;font-size:8.0pt"> et al. Translational Neurodegeneration</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt"> 2014,</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:8.0pt"> 3</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">:5</span></p>
<p style="top:44.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">http://www.translationalneurodegeneration.com/content/3/1/5</span></p>


<p style="top:88.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">been helpful to measure the impact of treatments on</span></p>
<p style="top:100.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cognition. Animal models of PD provide a more readily</span></p>
<p style="top:112.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">controlled means to assess cellular dysfunction, neuro-</span></p>
<p style="top:124.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">chemical alterations and other neural mechanisms that</span></p>
<p style="top:136.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">may contribute to disease pathogenesis in humans.</span></p>
<p style="top:148.9pt;left:64.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Exercise is thought to improve overall wellbeing in</span></p>
<p style="top:160.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">older adults and benefit cognitive functions of those with</span></p>
<p style="top:172.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">neurodegenerative diseases [7]. It has been suggested</span></p>
<p style="top:184.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">that exercise may improve the motor manifestations of</span></p>
<p style="top:196.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">PD and that restricted use in rats may potentiate neuro-</span></p>
<p style="top:208.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">degeneration [8]. Specifically, evidence has shown that</span></p>
<p style="top:220.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">exercise is beneficial for bradykinesia, postural balance</span></p>
<p style="top:232.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and quality of life in patients with PD [9-12]. The extent</span></p>
<p style="top:244.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">to which exercise specifically impacts cognition in PD,</span></p>
<p style="top:256.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and how, is unclear. A non-systematic review from 2011</span></p>
<p style="top:268.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">suggested that vigorous exercise may have a neuroprotec-</span></p>
<p style="top:280.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tive effect in PD [13]. A more recent systematic review</span></p>
<p style="top:292.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">similarly showed that non-pharmacological interventions</span></p>
<p style="top:304.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">improve cognition in PD. However, this review included</span></p>
<p style="top:316.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">only those studies published before December 2011 and</span></p>
<p style="top:328.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">used limited search terms related to cognition, resulting in</span></p>
<p style="top:340.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">the review of only four clinical studies [14]. A subsequent</span></p>
<p style="top:352.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">analysis of the literature was needed to include recent</span></p>
<p style="top:364.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">clinical studies and to incorporate animal-based research</span></p>
<p style="top:376.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">that might help identify potential mechanisms in humans.</span></p>
<p style="top:388.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Therefore, this systematic review was conducted to evalu-</span></p>
<p style="top:400.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ate all original research reports that assessed exercise in-</span></p>
<p style="top:412.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">terventions in human PD or in animal models of PD, with</span></p>
<p style="top:424.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">a primary or secondary outcome to examine cognitive</span></p>
<p style="top:436.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">function. To provide the most comprehensive overview of</span></p>
<p style="top:448.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">the literature, non-randomized, pre-post and cohort trials</span></p>
<p style="top:460.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">were included in addition to randomized controlled trials.</span></p>
<p style="top:472.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">The combination of these findings should be used to fur-</span></p>
<p style="top:484.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ther guide clinical practice and neurorehabilitation exer-</span></p>
<p style="top:496.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cise programs toward treating cognitive deficits in PD.</span></p>
<p style="top:520.5pt;left:56.7pt;line-height:10.3pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:10.3pt">Methods</span></p>
<p style="top:533.4pt;left:56.7pt;line-height:9.2pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:9.2pt">Systematic review protocol</span></p>
<p style="top:544.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">This systematic review was conducted according to the Pre-</span></p>
<p style="top:556.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ferred Reporting Items for Systematic reviews and Meta-</span></p>
<p style="top:568.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Analyses (PRISMA) statement guidelines [15]. The PRISMA</span></p>
<p style="top:580.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">statement includes a 27-item checklist (Additional file 1)</span></p>
<p style="top:592.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and standardized instructions for conducting a systematic</span></p>
<p style="top:604.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">review. The complete search methodology, information</span></p>
<p style="top:616.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">sources and results for this review are described within this</span></p>
<p style="top:628.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">report and Appendix 1.</span></p>
<p style="top:653.4pt;left:56.7pt;line-height:9.2pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:9.2pt">Eligibility criteria for study characteristics</span></p>
<p style="top:664.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">The participants included healthy human subjects, sub-</span></p>
<p style="top:676.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">jects with PD and animals with experimental PD. Studies</span></p>
<p style="top:688.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">were included if their primary intervention was exercise</span></p>
<p style="top:700.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and their primary or secondary outcomes were to assess</span></p>
<p style="top:712.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">either behavioral or neurobiological markers of cognitive</span></p>
<p style="top:724.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">function. All articles were included where the authors</span></p>
<p style="top:88.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">treated the outcome measure as a test of cognition. In</span></p>
<p style="top:100.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">some cases, the measure was a surrogate (e.g., biomarker</span></p>
<p style="top:112.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">associated with cognitive function), was a sub-score of</span></p>
<p style="top:124.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cognition from a larger scale, or was influenced by</span></p>
<p style="top:136.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">motor capacity. An exercise intervention was defined as</span></p>
<p style="top:148.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">any purposeful increase in the subject</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x2019;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">s physical activity</span></p>
<p style="top:160.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">through a single bout of exercise or prolonged exercise</span></p>
<p style="top:172.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">over the course of a structured or unstructured program.</span></p>
<p style="top:184.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Cohort and experimental study designs were included,</span></p>
<p style="top:196.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">whereas case series, case</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x2013;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">control, cross-sectional and</span></p>
<p style="top:208.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">descriptive studies were excluded. Original research arti-</span></p>
<p style="top:220.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cles were included from 1966 through October 2013.</span></p>
<p style="top:232.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Studies were considered if they were written in the</span></p>
<p style="top:244.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">English language and either published or</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt"> &#x201c;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">in press</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201d;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">.</span></p>
<p style="top:268.5pt;left:304.7pt;line-height:10.3pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:10.3pt">Results</span></p>
<p style="top:281.4pt;left:304.7pt;line-height:9.2pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:9.2pt">Study selection and synthesis</span></p>
<p style="top:292.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">There were 14 records included in this analysis (Figure 1).</span></p>
<p style="top:304.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Thirteen records were found through searching databases</span></p>
<p style="top:316.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and one record [16] was found through searching the ref-</span></p>
<p style="top:328.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">erences of articles identified for inclusion in the analysis.</span></p>
<p style="top:340.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">The records comprised six pre-clinical animal studies (all</span></p>
<p style="top:352.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">on rodents) and eight clinical studies in humans. Of the</span></p>
<p style="top:364.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">six pre-clinical studies, all were randomized controlled</span></p>
<p style="top:376.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">studies. Two studies examined the effects of exercise on</span></p>
<p style="top:388.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">unspecified aspects of cognition [17,18], and four studies</span></p>
<p style="top:400.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">examined the effects of exercise specifically on learning</span></p>
<p style="top:412.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and memory [16,19-21]. Of the eight clinical studies, four</span></p>
<p style="top:424.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">studies examined the effects of exercise on unspecified as-</span></p>
<p style="top:436.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">pects of cognition [22-25], and four studies examined the</span></p>
<p style="top:448.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">effects of exercise specifically on tasks of executive func-</span></p>
<p style="top:460.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tion [26-29]. The clinical studies included five randomized</span></p>
<p style="top:472.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">controlled trials, one controlled trial and two pre-post tri-</span></p>
<p style="top:484.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">als. A quantitative comparison or meta-analysis could not</span></p>
<p style="top:496.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">be performed for either the pre-clinical or clinical studies</span></p>
<p style="top:508.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">because there were only a small number of reports identi-</span></p>
<p style="top:520.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">fied, and when compiled together they had heterogeneous</span></p>
<p style="top:532.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">patient populations, exercise interventions and outcome</span></p>
<p style="top:544.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">measures.</span></p>
<p style="top:569.4pt;left:304.7pt;line-height:9.2pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:9.2pt">Study characteristics and results for pre-clinical studies</span></p>
<p style="top:580.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">All six pre-clinical studies were randomized controlled trials.</span></p>
<p style="top:592.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Three different toxins were used to generate basal ganglia le-</span></p>
<p style="top:604.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">sions and develop models of PD in rodents. Three studies</span></p>
<p style="top:616.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">used 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)</span></p>
<p style="top:628.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">in mice [16,17,20], two studies used 6-hydroxydopamine</span></p>
<p style="top:640.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">(6-OHDA) in rats [18,30], and one study used reser-</span></p>
<p style="top:652.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">pine in rats [19], resulting in reversible monoamine de-</span></p>
<p style="top:664.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">pletion. The timing of toxin administration varied</span></p>
<p style="top:676.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">relative to the onset of the exercise program. Four</span></p>
<p style="top:688.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">studies tested the effect of exercise that started follow-</span></p>
<p style="top:700.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ing the lesion [16-18,30]. The interventions were five</span></p>
<p style="top:712.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">days per week for 30 days starting within a week after</span></p>
<p style="top:724.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">administration of either MPTP or 6-OHDA. One study</span></p>
<p style="top:34.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Murray</span><span style="font-family:QcghtbAdvTT7329fd89.I,serif;font-size:8.0pt"> et al. Translational Neurodegeneration</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt"> 2014,</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:8.0pt"> 3</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">:5</span></p>
<p style="top:34.0pt;left:496.1pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Page 2 of 13</span></p>
<p style="top:44.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">http://www.translationalneurodegeneration.com/content/3/1/5</span></p>


<p style="top:460.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tested the effects of exercise for one week before, five</span></p>
<p style="top:472.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">weeks during, and for 8</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x2013;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">12 weeks following chronic</span></p>
<p style="top:484.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">MPTP administration [20]. The study that used reserpine</span></p>
<p style="top:496.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tested exercise five days per week for 30 days prior to ad-</span></p>
<p style="top:508.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ministration of the toxin in order to assess how exercise</span></p>
<p style="top:520.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">may prevent cognitive impairment in PD [19].</span></p>
<p style="top:532.9pt;left:64.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Four studies looked at forced exercise on a treadmill</span></p>
<p style="top:544.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">compared to no exercise [16,18,20,30]. Three studies</span></p>
<p style="top:556.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">showed potential neurobiological correlates of observed</span></p>
<p style="top:568.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">behavioral changes that the authors related to cognition,</span></p>
<p style="top:580.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">including findings from one study that rats forced to ex-</span></p>
<p style="top:592.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ercise had better behavioral recovery on tests of motor</span></p>
<p style="top:604.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">function (i.e., cylinder and amphetamine-induced rota-</span></p>
<p style="top:616.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tional tests), and better preservation of tyrosine hydroxy-</span></p>
<p style="top:628.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">lase immunoreactivity in both striatum and substantia</span></p>
<p style="top:640.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">nigra [18]. The authors also found that exercise in-</span></p>
<p style="top:652.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">creased the migration of BrdU and doublecortin-positive</span></p>
<p style="top:664.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cells as well as increased brain-derived neurotrophic fac-</span></p>
<p style="top:676.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tor (BDNF) and glial cell line-derived neurotrophic fac-</span></p>
<p style="top:688.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tor (GDNF) in the striatum on the side of the lesion. In</span></p>
<p style="top:700.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">another study, exercise resulted in enhanced duration</span></p>
<p style="top:712.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and velocity of running behavior, indicating that rats had</span></p>
<p style="top:724.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">learned to maintain a forward position on a treadmill</span></p>
<p style="top:460.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">[16]. Exercise in these MPTP- and saline-injected mice</span></p>
<p style="top:472.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">resulted in significant down-regulation of striatal dopa-</span></p>
<p style="top:484.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">mine transporter protein (DAT) as well as increased D</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:6.9pt">2</span></p>
<p style="top:496.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">(but not D</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:6.9pt">1</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">) receptor mRNA expression. Exercise atten-</span></p>
<p style="top:508.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">uated the increase in striatal glutamate nerve terminal</span></p>
<p style="top:520.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">labeling following MPTP, but there was no change in</span></p>
<p style="top:532.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">glutamate immunolabeling in CA1 in the hippocampus.</span></p>
<p style="top:544.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">In both of these studies exercise improved behavioral</span></p>
<p style="top:556.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">markers that were interpreted by the authors as indica-</span></p>
<p style="top:568.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tive of enhanced cognitive function. It should be noted</span></p>
<p style="top:580.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">that these measures rely heavily on motor capacity and</span></p>
<p style="top:592.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">are typically associated more with motor than with cog-</span></p>
<p style="top:604.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">nitive function. The third study that showed neurobio-</span></p>
<p style="top:616.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">logical changes associated with corresponding behavioral</span></p>
<p style="top:628.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">changes tested effects of aerobic swimming in mice. The</span></p>
<p style="top:640.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">rodents showed improved long-term memory on a test</span></p>
<p style="top:652.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">of object recognition following exercise and had at-</span></p>
<p style="top:664.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tenuation of impairments from exposure to 6-OHDA,</span></p>
<p style="top:676.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">including decreased pro-inflammatory cytokines, im-</span></p>
<p style="top:688.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">proved markers of oxidative stress and increased DA</span></p>
<p style="top:700.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">transmission [30]. The last study that looked at forced</span></p>
<p style="top:712.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">exercise on a treadmill compared to no exercise con-</span></p>
<p style="top:724.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ducted in a chronic model of PD found that endurance</span></p>
<p style="top:110.2pt;left:194.2pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">351 records</span></p>
<p style="top:123.3pt;left:181.8pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">identified through </span></p>
<p style="top:136.5pt;left:179.6pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">electronic database</span></p>
<p style="top:110.2pt;left:283.8pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">33 additional records</span></p>
<p style="top:123.3pt;left:290.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">identified through</span></p>
<p style="top:136.5pt;left:288.9pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ancestry searching</span></p>
<p style="top:303.5pt;left:354.6pt;line-height:8.3pt"><span style="font-family:Times New Roman,serif;font-size:8.3pt">102 records excluded</span></p>
<p style="top:313.7pt;left:373.5pt;line-height:8.3pt"><span style="font-family:Times New Roman,serif;font-size:8.3pt">47: non-original research </span></p>
<p style="top:323.2pt;left:373.5pt;line-height:8.3pt"><span style="font-family:Times New Roman,serif;font-size:8.3pt">articles </span></p>
<p style="top:333.4pt;left:373.5pt;line-height:8.3pt"><span style="font-family:Times New Roman,serif;font-size:8.3pt">33: cognition was not the </span></p>
<p style="top:342.8pt;left:373.5pt;line-height:8.3pt"><span style="font-family:Times New Roman,serif;font-size:8.3pt">primary outcome</span></p>
<p style="top:353.0pt;left:374.4pt;line-height:8.3pt"><span style="font-family:Times New Roman,serif;font-size:8.3pt">14 : exercise was not the  </span></p>
<p style="top:362.5pt;left:373.5pt;line-height:8.3pt"><span style="font-family:Times New Roman,serif;font-size:8.3pt">primary intervention</span></p>
<p style="top:372.7pt;left:373.5pt;line-height:8.3pt"><span style="font-family:Times New Roman,serif;font-size:8.3pt">5: not on PD subjects</span></p>
<p style="top:382.9pt;left:373.5pt;line-height:8.3pt"><span style="font-family:Times New Roman,serif;font-size:8.3pt">3: case-reports/case-series </span></p>
<p style="top:384.4pt;left:227.1pt;line-height:10.0pt"><b><span style="font-family:Times New Roman,serif;font-size:10.0pt">14 records included </span></b></p>
<p style="top:397.5pt;left:223.2pt;line-height:10.0pt"><b><span style="font-family:Times New Roman,serif;font-size:10.0pt">in systematic review </span></b></p>
<p style="top:303.4pt;left:229.9pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">116 full-text records</span></p>
<p style="top:316.5pt;left:226.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">assessed for eligibility</span></p>
<p style="top:243.6pt;left:362.1pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">74 records excluded </span></p>
<p style="top:181.3pt;left:233.9pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">274 records after</span></p>
<p style="top:194.5pt;left:228.7pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">duplicates removed</span></p>
<p style="top:229.3pt;left:227.1pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">190 records screened </span></p>
<p style="top:242.5pt;left:234.1pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">based on title and </span></p>
<p style="top:255.8pt;left:249.7pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">keywords</span></p>
<p style="top:152.6pt;left:130.9pt;line-height:10.0pt"><b><span style="font-family:Times New Roman,serif;font-size:10.0pt">Identification</span></b></p>
<p style="top:238.9pt;left:131.2pt;line-height:10.0pt"><b><span style="font-family:Times New Roman,serif;font-size:10.0pt">Screening</span></b></p>
<p style="top:329.6pt;left:131.2pt;line-height:10.0pt"><b><span style="font-family:Times New Roman,serif;font-size:10.0pt">Eligibility</span></b></p>
<p style="top:408.8pt;left:131.2pt;line-height:10.0pt"><b><span style="font-family:Times New Roman,serif;font-size:10.0pt">Included</span></b></p>
<p style="top:189.8pt;left:362.1pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">84 records excluded</span></p>
<p style="top:433.9pt;left:62.7pt;line-height:8.0pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:8.0pt">Figure 1</span><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt"> PRISMA Flow Diagram of Study Selection.</span></p>
<p style="top:34.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Murray</span><span style="font-family:QcghtbAdvTT7329fd89.I,serif;font-size:8.0pt"> et al. Translational Neurodegeneration</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt"> 2014,</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:8.0pt"> 3</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">:5</span></p>
<p style="top:34.0pt;left:496.1pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Page 3 of 13</span></p>
<p style="top:44.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">http://www.translationalneurodegeneration.com/content/3/1/5</span></p>


<p style="top:88.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">exercise improved only motor function related to gait</span></p>
<p style="top:100.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ambulation and balance, with no improvement in cog-</span></p>
<p style="top:112.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">nitive measures [20]. This study was also the only one</span></p>
<p style="top:124.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">of these four where exercise did not improve a neuro-</span></p>
<p style="top:136.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">biological outcome following toxin administration, in-</span></p>
<p style="top:148.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cluding no raise in striatal DA and no reversed loss of</span></p>
<p style="top:160.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tyrosine-hydroxylase fibers in the substantia nigra pars</span></p>
<p style="top:172.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">compacta.</span></p>
<p style="top:184.9pt;left:64.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Two studies (one with MPTP and one with reserpine)</span></p>
<p style="top:196.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">looked at the effects of voluntary exercise (wheel run-</span></p>
<p style="top:208.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ning), compared to forced exercise on a treadmill or no</span></p>
<p style="top:220.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">exercise [17,19]. In one study, exercise was introduced</span></p>
<p style="top:232.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">prior to the administration of reserpine [19], while in the</span></p>
<p style="top:244.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">other [17], exercise was not initiated until after the</span></p>
<p style="top:256.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">MPTP lesion. Both studies found that either form of ex-</span></p>
<p style="top:268.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ercise improved behavior underlying cognitive capacity</span></p>
<p style="top:280.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">in a PD-like model. Interestingly, only forced exercise,</span></p>
<p style="top:292.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">following the lesion, improved a test of motor learning</span></p>
<p style="top:304.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">(transfer of treadmill performance to Rotarod). The au-</span></p>
<p style="top:316.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">thors suggested this finding reflects learning as the ani-</span></p>
<p style="top:328.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">mals had presumably transferred skill from the treadmill</span></p>
<p style="top:340.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">to the Rotarod task [17]. The rodents forced to exercise</span></p>
<p style="top:352.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">on the treadmill showed a greater improvement on the</span></p>
<p style="top:364.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Rotarod test, even though rodents on the wheel willingly</span></p>
<p style="top:376.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">spent more time exercising than those forced to run on</span></p>
<p style="top:388.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">the treadmill. Both voluntary and forced exercise had</span></p>
<p style="top:400.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">anxiolytic effects as assessed using the elevated plus</span></p>
<p style="top:412.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">maze, which the authors linked to cognition and mem-</span></p>
<p style="top:424.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ory, but neither type of exercise had any effect on de-</span></p>
<p style="top:436.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">pressive behavior as assessed by sucrose preference and</span></p>
<p style="top:448.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tail suspension. These improvements were not associ-</span></p>
<p style="top:460.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ated with changes in the striatal DA or amygdalar sero-</span></p>
<p style="top:472.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tonin (5HT) levels following the exercise intervention, as</span></p>
<p style="top:484.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">compared</span></p>
<p style="top:484.9pt;left:105.2pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">to</span></p>
<p style="top:484.9pt;left:121.4pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">saline-treated</span></p>
<p style="top:484.9pt;left:184.4pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">sedentary</span></p>
<p style="top:484.9pt;left:231.1pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">controls</span></p>
<p style="top:484.9pt;left:272.2pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">[17].</span></p>
<p style="top:496.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">However, both MPTP- and saline-treated mice had a</span></p>
<p style="top:508.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">similar relative increase in striatal DA following forced</span></p>
<p style="top:520.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">or voluntary exercise compared to saline-treated seden-</span></p>
<p style="top:532.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tary controls. Forced exercise also increased 5HT in the</span></p>
<p style="top:544.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">nucleus accumbens in the MPTP-treated mice compared</span></p>
<p style="top:556.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">to saline controls. In the second study, when either</span></p>
<p style="top:568.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">forced or voluntary exercise was introduced prior to re-</span></p>
<p style="top:580.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">serpine administration, both exercise paradigms resulted</span></p>
<p style="top:592.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">in improved motor learning on the Rotarod and open-</span></p>
<p style="top:604.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">field tasks (tests of exploratory activity), as well as im-</span></p>
<p style="top:616.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">proved social memory [19]. Social memory improved</span></p>
<p style="top:628.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">with a low dose or reserpine which, unlike the high dose</span></p>
<p style="top:640.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">of the toxin, did not affect the animals</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x2019;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> motor function.</span></p>
<p style="top:652.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Biomarkers were not assessed in this study.</span></p>
<p style="top:664.9pt;left:64.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Further details of study characteristics and results for</span></p>
<p style="top:676.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">pre-clinical studies are summarized in Tables 1 and 2.</span></p>
<p style="top:701.4pt;left:56.7pt;line-height:9.2pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:9.2pt">Major sources of risk of bias for pre-clinical studies</span></p>
<p style="top:712.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">One of the six pre-clinical animal studies was at risk of</span></p>
<p style="top:724.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">selection bias because the investigators did not include a</span></p>
<p style="top:88.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">saline-only control group or an exercise and probenecid</span></p>
<p style="top:100.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">group, although it was still a randomized controlled trial</span></p>
<p style="top:112.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">[20]. Three other pre-clinical studies were at risk of in-</span></p>
<p style="top:124.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">formation biases; in one case the cognitive assessment</span></p>
<p style="top:136.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">relied on motor capacity [16], in another case the behav-</span></p>
<p style="top:148.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ioral testing began soon after administration of the</span></p>
<p style="top:160.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">toxin, which may have interrupted the lesion process</span></p>
<p style="top:172.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">(not measured) and made the model less comparable to</span></p>
<p style="top:184.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">PD in human subjects [19] and in the third case the ex-</span></p>
<p style="top:196.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ercise was started soon after the toxin was administered,</span></p>
<p style="top:208.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">which may also have interrupted the lesion process [16].</span></p>
<p style="top:220.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Two studies had performance biases, specifically that</span></p>
<p style="top:232.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">each animal was only evaluated on one test [17] and that</span></p>
<p style="top:244.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">exercised mice were trained for swimming for two weeks</span></p>
<p style="top:256.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">before toxin administration and handled each session,</span></p>
<p style="top:268.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">whereas the sedentary animals were not trained or han-</span></p>
<p style="top:280.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">dled [30]. Additionally, the social interaction (i.e., hous-</span></p>
<p style="top:292.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ing environment) the animals experienced was different</span></p>
<p style="top:304.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">in each of the six studies, making it difficult to compare</span></p>
<p style="top:316.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">results across studies. The number of rodents housed in</span></p>
<p style="top:328.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">a cage ranged from one to ten, and one study did not</span></p>
<p style="top:340.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">specify the housing environment. Paired housing com-</span></p>
<p style="top:352.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">pared to single housing in rodents has been shown to</span></p>
<p style="top:364.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">mediate the effects of MPTP on nigrostriatal degener-</span></p>
<p style="top:376.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ation and motor behavior [31] and may have a substan-</span></p>
<p style="top:388.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tial effect on behavioral and histological outcomes. The</span></p>
<p style="top:400.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">risk of bias for each pre-clinical study is summarized in</span></p>
<p style="top:412.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Table 2.</span></p>
<p style="top:437.4pt;left:304.7pt;line-height:9.2pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:9.2pt">Study characteristics and results for clinical studies</span></p>
<p style="top:448.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">All eight studies showed that exercise improved a</span></p>
<p style="top:460.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">marker of cognition (Table 3). Based on the GRADE</span></p>
<p style="top:472.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ranking system, the quality of the evidence and strength of</span></p>
<p style="top:484.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">recommendations for the four studies on executive func-</span></p>
<p style="top:496.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tion were greater (</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201c;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">moderate</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201d;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> and</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt"> &#x201c;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">strong</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201d;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">) than for stud-</span></p>
<p style="top:508.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ies testing unspecified aspects of cognitive function (</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201c;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">low</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201d;</span></p>
<p style="top:520.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt"> &#x201c;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">weak</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201d;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">).</span></p>
<p style="top:532.9pt;left:312.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">The sample size for the eight clinical studies varied</span></p>
<p style="top:544.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">from six to 60 subjects, with a mean of 15 subjects per</span></p>
<p style="top:556.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">group. The PD participants had a mean age between 60</span></p>
<p style="top:568.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">to 70 years and had mild to moderate PD according to</span></p>
<p style="top:580.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">the Hoehn and Yahr scale [34], and were compared to</span></p>
<p style="top:592.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">age-matched healthy control subjects. All of these stud-</span></p>
<p style="top:604.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ies examined subjects while they were taking their regu-</span></p>
<p style="top:616.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">larly prescribed medication. These studies did not report</span></p>
<p style="top:628.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">when subjects took their regular medication and which</span></p>
<p style="top:640.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">medications they continued to take during the study.</span></p>
<p style="top:652.9pt;left:312.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Each of the four studies that tested the effect of exer-</span></p>
<p style="top:664.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cise on unspecified aspects of cognition found benefits</span></p>
<p style="top:676.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">on general markers of overall function which the authors</span></p>
<p style="top:688.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">related to cognition, including the cognition component</span></p>
<p style="top:700.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">of PDQ-39, MoCA, memory, reaction time and peg in-</span></p>
<p style="top:712.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">sertion time (requiring visual and spatial cognition, sort-</span></p>
<p style="top:724.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ing and planning) [22-25]. The evidence from two of the</span></p>
<p style="top:34.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Murray</span><span style="font-family:QcghtbAdvTT7329fd89.I,serif;font-size:8.0pt"> et al. Translational Neurodegeneration</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt"> 2014,</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:8.0pt"> 3</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">:5</span></p>
<p style="top:34.0pt;left:496.1pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Page 4 of 13</span></p>
<p style="top:44.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">http://www.translationalneurodegeneration.com/content/3/1/5</span></p>


<p style="top:472.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">studies is limited as they were pilot trials designed to test</span></p>
<p style="top:484.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">feasibility [22,23]. Additionally, the measures of cogni-</span></p>
<p style="top:496.8pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tion these studies used, the cognition component of</span></p>
<p style="top:508.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">PDQ-39, reaction time and peg insertion, are not clear</span></p>
<p style="top:520.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">measures of cognitive function. However, the two other</span></p>
<p style="top:532.8pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">studies clearly demonstrated that exercise had an effect</span></p>
<p style="top:544.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">on cognitive capacity [24,25]. Of these two trials, both</span></p>
<p style="top:556.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tested the Wii Fit</span><sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:6.9pt">TM</span></sup><sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> </span></sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">program. They showed that after</span></p>
<p style="top:568.8pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">training, PD subjects can retain and transfer learning, de-</span></p>
<p style="top:580.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">pending on the cognitive demands of the game, [25] but</span></p>
<p style="top:592.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Wii Fit</span><sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:6.9pt">TM</span></sup><sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> </span></sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">may not provide additional advantage in com-</span></p>
<p style="top:604.8pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">parison to balance exercises without cognitive stimulation</span></p>
<p style="top:616.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">or feedback [24].</span></p>
<p style="top:628.9pt;left:64.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Across studies, exercise interventions varied signifi-</span></p>
<p style="top:640.8pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cantly in terms of the intensity, mode and duration of</span></p>
<p style="top:652.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">the program. One study involved an individualized walk-</span></p>
<p style="top:664.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ing program (</span><span style="font-family:MjdkrqAdvTT8861b38f.I,serif;font-size:9.8pt">PoleStriding</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">) using Nordic poles three</span></p>
<p style="top:676.8pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">times per week for eight weeks [22]. Another study</span></p>
<p style="top:688.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">assessed outcomes before and after a single bout of</span></p>
<p style="top:700.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">high-intensity cycling [23]. The two studies that used the</span></p>
<p style="top:712.8pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Wii Fit</span><sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:6.9pt">TM</span></sup><sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> </span></sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">program for their exercise intervention in-</span></p>
<p style="top:724.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cluded two sessions per week for seven weeks and</span></p>
<p style="top:472.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">follow-up after 60 days [24,25]. One of the two studies</span></p>
<p style="top:484.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">using Wii Fit</span><sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:6.9pt">TM</span></sup><sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> </span></sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">compared PD subjects to healthy con-</span></p>
<p style="top:496.8pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">trols [25] and the other study looked at differences be-</span></p>
<p style="top:508.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tween PD subjects participating in the combined Wii</span></p>
<p style="top:520.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Fit</span><sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:6.9pt">TM</span></sup><sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> </span></sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">program with balance-based and cognitive training</span></p>
<p style="top:532.8pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">compared to multimodal global exercises [24].</span></p>
<p style="top:544.9pt;left:312.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Each of the four studies that specifically tested execu-</span></p>
<p style="top:556.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tive function showed that exercise improved perform-</span></p>
<p style="top:568.8pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ance on some measure of executive function, such as</span></p>
<p style="top:580.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tests of abstraction, mental flexibility, spatial working</span></p>
<p style="top:592.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">memory, verbal fluency, mental imagery, and cognitive</span></p>
<p style="top:604.8pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">processing speed [26-29]. The tools used to test execu-</span></p>
<p style="top:616.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tive function include the Wisconsin Card Sorting Task,</span></p>
<p style="top:628.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Trail-Making Test A and B, Cambridge Neuropsycho-</span></p>
<p style="top:640.8pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">logical Test Automated Battery, and tests of verbal and</span></p>
<p style="top:652.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">semantic fluency. Two studies assessed mood as a po-</span></p>
<p style="top:664.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tential confounding factor affecting executive function;</span></p>
<p style="top:676.8pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">one study found that exercise improved executive func-</span></p>
<p style="top:688.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tion independent of improvements in mood, attention,</span></p>
<p style="top:700.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">disease-specific quality of life or reduced anxiety [27].</span></p>
<p style="top:712.8pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Another study found that exercise possibly improved</span></p>
<p style="top:724.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">mood, but did not affect quality of life [26]. This lack of</span></p>
<p style="top:89.3pt;left:56.7pt;line-height:9.0pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:9.0pt">Table 1 Study characteristics of pre-clinical studies on rodent models of Parkinson</span><span style="font-family:KgvwbyAdvTTaf7f9f4f.B+20,serif;font-size:9.0pt">&#x2019;</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:9.0pt">s disease</span></p>
<p style="top:103.2pt;left:56.7pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Authors</span></p>
<p style="top:103.2pt;left:138.4pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Study title</span></p>
<p style="top:103.2pt;left:280.2pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Subjects</span></p>
<p style="top:103.2pt;left:423.7pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Intervention</span></p>
<p style="top:116.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Goes et al., 2013 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">21</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:116.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Neuroprotective effects of swimming</span></p>
<p style="top:125.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">training in a mouse model of Parkinson</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2019;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">s</span></p>
<p style="top:134.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">disease induced by 6-hydroxydopamine</span></p>
<p style="top:116.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 2 groups (n = 20 each): 6-OHDA, saline</span></p>
<p style="top:116.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 20</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">60 min/day, 5 days/week</span></p>
<p style="top:125.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">for 4 weeks</span></p>
<p style="top:130.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 2 treatment cohorts (n = 10 each):</span></p>
<p style="top:139.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">swimming training, no exercise</span></p>
<p style="top:139.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Starting 4 days after toxin</span></p>
<p style="top:148.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">administration</span></p>
<p style="top:162.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Gorton et al., 2010 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">17</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:162.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Exercise effects on motor and</span></p>
<p style="top:171.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">affective behavior and catecholamine</span></p>
<p style="top:180.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">neurochemistry in the MPTP-lesioned</span></p>
<p style="top:189.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">mouse</span></p>
<p style="top:162.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 2 groups (n = 24 each): MPTP, saline</span></p>
<p style="top:162.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Up to 1 hr/day, 5 days/week</span></p>
<p style="top:171.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">for 4 weeks</span></p>
<p style="top:176.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 3 treatment cohorts (n = 8/group):</span></p>
<p style="top:185.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">forced exercise, voluntary exercise,</span></p>
<p style="top:194.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">no exercise</span></p>
<p style="top:185.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Starting 5 days after toxin</span></p>
<p style="top:194.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">administration</span></p>
<p style="top:208.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Tajiri et al., 2010 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">18</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:208.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Exercise exerts neuroprotective effects</span></p>
<p style="top:217.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">on Parkinson&apos;s disease model of rats</span></p>
<p style="top:208.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 1 group (n = 60): 6-OHDA</span></p>
<p style="top:208.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 30 min/day, 5 days/week for</span></p>
<p style="top:217.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">4 weeks</span></p>
<p style="top:222.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 2 treatment cohorts (n = 30 each):</span></p>
<p style="top:231.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">forced exercise, no exercise</span></p>
<p style="top:231.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Starting 1 day after toxin</span></p>
<p style="top:240.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">administration</span></p>
<p style="top:254.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Aguiar et al., 2009 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">19</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:254.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Physical exercise improves motor and</span></p>
<p style="top:263.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">short-term social memory deficits in</span></p>
<p style="top:272.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">reserpinized rats</span></p>
<p style="top:254.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 4 groups (n = 24 each): high/low</span></p>
<p style="top:263.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">dose reserpine or high/low dose</span></p>
<p style="top:272.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">saline</span></p>
<p style="top:254.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 20</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">25 min/day, 5 days/week</span></p>
<p style="top:263.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">for 4 weeks</span></p>
<p style="top:277.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Starting 4 weeks before toxin</span></p>
<p style="top:286.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">administration</span></p>
<p style="top:286.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 3 treatment cohorts</span><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:5.7pt">&#xb1;</span></sup><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> </span></sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">(n = 8/group):</span></p>
<p style="top:295.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">forced exercise, voluntary exercise,</span></p>
<p style="top:304.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">no exercise</span></p>
<p style="top:318.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Pothakos et al., 2009</span></p>
<p style="top:327.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">[</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">20</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:318.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Restorative effect of endurance exercise</span></p>
<p style="top:327.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">on behavioral deficits in the chronic</span></p>
<p style="top:336.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">mouse model of Parkinson&apos;s disease</span></p>
<p style="top:345.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">with severe neurodegeneration</span></p>
<p style="top:318.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 2 groups (n = 29 each): probenecid/MPTP</span></p>
<p style="top:327.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">(model of chronic PD), probenecid only</span></p>
<p style="top:318.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 40 min/day, 5 days/week for</span></p>
<p style="top:327.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">8</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">12 weeks</span></p>
<p style="top:341.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Starting 1 week before, 5 weeks</span></p>
<p style="top:350.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">during, 8</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">12 weeks after toxin</span></p>
<p style="top:359.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">administration</span></p>
<p style="top:341.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 2 treatment cohorts (n = 5-10/group):</span></p>
<p style="top:350.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">forced endurance exercise, no</span></p>
<p style="top:359.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">exercise</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt"> &#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> for probenicid/MPTP group</span></p>
<p style="top:368.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">only</span></p>
<p style="top:382.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Fisher et al., 2004 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">16</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:382.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Exercise-induced behavioral recovery and</span></p>
<p style="top:391.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">neuroplasticity in the 1-methyl-4-phenyl-1,</span></p>
<p style="top:400.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">2,3,6-tetrahydropyridine- lesioned mouse</span></p>
<p style="top:409.4pt;left:138.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">basal ganglia</span></p>
<p style="top:382.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 2 groups (n = 60 each): MPTP, saline</span></p>
<p style="top:382.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Up to 2x 30 min/day, 5 days/week</span></p>
<p style="top:391.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">for 4 weeks</span></p>
<p style="top:396.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> 2 treatment cohorts (n = 20/group):</span></p>
<p style="top:405.4pt;left:280.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">forced exercise, no exercise*</span></p>
<p style="top:405.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Starting 4 days after toxin</span></p>
<p style="top:414.4pt;left:423.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">administration</span></p>
<p style="top:426.9pt;left:56.7pt;line-height:4.9pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:4.9pt">&#xb1;</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.0pt">Only rats able to maintain a forward position on the treadmill were assigned to the treadmill exercise group.</span></p>
<p style="top:436.8pt;left:56.7pt;line-height:7.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.0pt">*Only rats able to maintain a forward position on the treadmill were randomized to either exercise or no exercise cohort.</span></p>
<p style="top:34.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Murray</span><span style="font-family:QcghtbAdvTT7329fd89.I,serif;font-size:8.0pt"> et al. Translational Neurodegeneration</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt"> 2014,</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:8.0pt"> 3</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">:5</span></p>
<p style="top:34.0pt;left:496.1pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Page 5 of 13</span></p>
<p style="top:44.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">http://www.translationalneurodegeneration.com/content/3/1/5</span></p>


<p style="top:89.3pt;left:56.7pt;line-height:9.0pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:9.0pt">Table 2 Outcomes and risk of bias for pre-clinical studies on rodent models of Parkinson</span><span style="font-family:KgvwbyAdvTTaf7f9f4f.B+20,serif;font-size:9.0pt">&#x2019;</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:9.0pt">s disease</span></p>
<p style="top:103.2pt;left:56.7pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Study</span></p>
<p style="top:103.2pt;left:138.2pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Behavioral outcomes</span></p>
<p style="top:103.2pt;left:273.5pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Neurobiological outcomes</span></p>
<p style="top:103.2pt;left:418.3pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Major sources of risk of bias</span></p>
<p style="top:116.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Goes et al., 2013 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">21</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:116.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Forced exercise following onset of</span></p>
<p style="top:125.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">experimental PD:</span></p>
<p style="top:116.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Changes in the striatum from forced exercise</span></p>
<p style="top:125.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">following onset of experimental PD:</span></p>
<p style="top:116.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Performance bias: sedentary control</span></p>
<p style="top:125.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">animals were not exposed to the</span></p>
<p style="top:134.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">swimming training program, the</span></p>
<p style="top:143.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">warm water or handled to be dried</span></p>
<p style="top:152.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">off following each session.</span></p>
<p style="top:139.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Decreased marker of depression</span></p>
<p style="top:148.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">(tail suspension)</span></p>
<p style="top:139.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Decreased interleukin 1-beta levels</span></p>
<p style="top:148.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">(proinflammatory cytokines)</span></p>
<p style="top:162.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Improved motor coordination</span></p>
<p style="top:171.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">(decreased falls on Rotarod test)</span></p>
<p style="top:162.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Attenuated inhibition of glutathione</span></p>
<p style="top:171.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">peroxidase activity, decreased glutathione</span></p>
<p style="top:180.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">reductase and glutathione S-transferase</span></p>
<p style="top:189.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">activity (all markers of oxidative stress)</span></p>
<p style="top:185.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Improved long-term memory,</span></p>
<p style="top:194.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">but not short-term memory in</span></p>
<p style="top:203.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">object recognition test</span></p>
<p style="top:203.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Increased dopamine, homovanillic acid,</span></p>
<p style="top:212.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">and 3,4-dihydroxyphenylacetic acid levels</span></p>
<p style="top:226.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Gorton et al., 2010 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">17</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:226.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Forced and voluntary exercise</span></p>
<p style="top:235.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">following onset of experimental PD:</span></p>
<p style="top:226.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Forced and voluntary exercise following</span></p>
<p style="top:235.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">onset of experimental PD:</span></p>
<p style="top:226.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Performance bias: each animal was</span></p>
<p style="top:235.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">only evaluated on one test.</span></p>
<p style="top:249.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Improved motor learning (Rotarod)</span></p>
<p style="top:249.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Had no effect on levels of DA in the</span></p>
<p style="top:258.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">striatum and serotonin in the amygdala</span></p>
<p style="top:267.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">compared to saline controls</span></p>
<p style="top:263.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Reduced anxiety in elevated</span></p>
<p style="top:272.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">plus maze (passive avoidance</span></p>
<p style="top:281.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">task, authors linked to</span></p>
<p style="top:290.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">cognition/memory)</span></p>
<p style="top:281.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Forced and voluntary exercise increased</span></p>
<p style="top:290.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">DA in the striatum to similar levels</span></p>
<p style="top:299.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">following MPTP or saline administration</span></p>
<p style="top:304.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Had no effect on markers of</span></p>
<p style="top:313.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">depression, sucrose preference</span></p>
<p style="top:322.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">and tail suspension (MPTP lesion</span></p>
<p style="top:331.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">also had no effect)</span></p>
<p style="top:313.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Forced exercise increased 5HT in the</span></p>
<p style="top:322.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">nucleus accumbens in MPTP-treated</span></p>
<p style="top:331.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">mice compared to saline controls</span></p>
<p style="top:345.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Tajiri et al., 2010 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">18</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:345.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Exercise following onset of experimental</span></p>
<p style="top:354.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">PD:</span></p>
<p style="top:345.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Exercise following onset of experimental</span></p>
<p style="top:354.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">PD:</span></p>
<p style="top:345.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Information bias: exercise was started</span></p>
<p style="top:354.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">soon (24 hrs) after toxin administration,</span></p>
<p style="top:363.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">so the lesion may not represent a</span></p>
<p style="top:372.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">complete PD-like model.</span></p>
<p style="top:368.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Improved cylinder test, amphetamine-</span></p>
<p style="top:377.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">induced rotational test (authors linked</span></p>
<p style="top:386.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">to cognitive-related behavior)</span></p>
<p style="top:368.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Preserved nigrostriatal dopamine neurons</span></p>
<p style="top:377.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">(increased tyrosine hydroxylase-positive</span></p>
<p style="top:386.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">fibers)</span></p>
<p style="top:400.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Increased migration of new-born neural</span></p>
<p style="top:409.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">stem/progenitor cells toward striatum</span></p>
<p style="top:423.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Up-regulated neurotrophic factors, BDNF</span></p>
<p style="top:432.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">and GDNF, in the striatum</span></p>
<p style="top:446.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Aguiar et al., 2009 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">19</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:446.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Forced and voluntary exercise before</span></p>
<p style="top:455.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">onset of experimental PD:</span></p>
<p style="top:446.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Neurobiological outcomes not assessed</span></p>
<p style="top:446.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Information bias: behavioral testing</span></p>
<p style="top:455.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">was soon (24 hrs) after the reserpine</span></p>
<p style="top:464.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">administration, so the lesion may not</span></p>
<p style="top:473.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">represent a complete PD-like model.</span></p>
<p style="top:469.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Improved motor deficits following a</span></p>
<p style="top:478.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">high dose of reserpine</span></p>
<p style="top:492.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Improved short-term social memory</span></p>
<p style="top:501.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">(tested through olfactory discrimination),</span></p>
<p style="top:510.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">with no deficit on motor or olfactory</span></p>
<p style="top:519.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">function from the low dose of reserpine</span></p>
<p style="top:533.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Pothakos et al., 2009 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">20</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:533.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Endurance exercise before and following</span></p>
<p style="top:542.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">onset of experimental chronic PD</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">:</span></p>
<p style="top:533.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Endurance exercise before and after onset</span></p>
<p style="top:542.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">of experimental chronic PD:</span></p>
<p style="top:533.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Selection biases: there was not a group</span></p>
<p style="top:542.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">that received exercise and probenecid.</span></p>
<p style="top:551.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">There was also not a control group</span></p>
<p style="top:560.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">with only a saline injection. The effects</span></p>
<p style="top:569.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">of the control solution, probenecid, on</span></p>
<p style="top:578.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">cognition are not known.</span></p>
<p style="top:556.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Reversed balance and gait performance,</span></p>
<p style="top:565.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">restored regular movement</span></p>
<p style="top:556.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Did not raise striatal DA (n = 6)</span></p>
<p style="top:570.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Did not reverse loss of tyrosine-hydroxylase</span></p>
<p style="top:579.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">fibers in substantia nigra (pars compacta)</span></p>
<p style="top:579.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Had no effect on learning (cued Morris</span></p>
<p style="top:588.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">water maze), amphetamine-stimulated</span></p>
<p style="top:597.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">locomotion or motor coordination</span></p>
<p style="top:611.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Fisher et al., 2004 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">16</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:611.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Exercise following onset of experimental PD:</span></p>
<p style="top:611.4pt;left:273.5pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Exercise following onset of experimental PD:</span></p>
<p style="top:611.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Information bias: the learning paradigm</span></p>
<p style="top:620.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">for behavioral results (learning to stay</span></p>
<p style="top:629.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">on the treadmill) relied substantially on</span></p>
<p style="top:638.4pt;left:418.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">motor capacity.</span></p>
<p style="top:625.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Improved velocity and endurance on</span></p>
<p style="top:634.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">treadmill</span></p>
<p style="top:625.4pt;left:273.4pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Had no effect on tyrosine hydroxylase</span></p>
<p style="top:648.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Sensory feedback not needed over time</span></p>
<p style="top:657.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">for behavioral response (i.e., maintaining</span></p>
<p style="top:666.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">a forward position on treadmill), authors</span></p>
<p style="top:675.4pt;left:138.2pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">suggested indicative of learning</span></p>
<p style="top:638.8pt;left:273.4pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Up-regulated dopamine D</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:5.7pt">2</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> receptor mRNA</span></p>
<p style="top:647.8pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">expression</span></p>
<p style="top:661.8pt;left:273.4pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Down-regulated striatal DAT</span></p>
<p style="top:675.8pt;left:273.4pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Reversed increased nerve terminal</span></p>
<p style="top:684.8pt;left:273.4pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">glutamate in striatum (as a result of MPTP)</span></p>
<p style="top:34.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Murray</span><span style="font-family:QcghtbAdvTT7329fd89.I,serif;font-size:8.0pt"> et al. Translational Neurodegeneration</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt"> 2014,</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:8.0pt"> 3</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">:5</span></p>
<p style="top:34.0pt;left:496.1pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Page 6 of 13</span></p>
<p style="top:44.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">http://www.translationalneurodegeneration.com/content/3/1/5</span></p>


<p style="top:328.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">impact on quality of life is interesting given that this</span></p>
<p style="top:340.7pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">study did not control for the benefits of social inter-</span></p>
<p style="top:352.7pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">action received by the exercise group in comparison to</span></p>
<p style="top:364.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">the control group, who were instructed to continue</span></p>
<p style="top:376.7pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">with their normal routine. Both low-intensity passive</span></p>
<p style="top:388.7pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">aerobic cycling [28] as well as moderate-intensity aer-</span></p>
<p style="top:400.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">obic and anabolic exercise [26,27] were found to im-</span></p>
<p style="top:412.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">prove executive function in PD. The fourth study</span></p>
<p style="top:424.7pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">differed from the other exercise interventions because</span></p>
<p style="top:436.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">it assessed 20 sessions of tango classes compared to</span></p>
<p style="top:448.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">education over 12 weeks. The subjects were assessed</span></p>
<p style="top:460.7pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">for cognitive function 10</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x2013;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">12 weeks following the inter-</span></p>
<p style="top:472.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">vention. Subjects in the tango arm improved on the</span></p>
<p style="top:484.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Brooks Spatial Task, a test of spatial cognition (i.e.,</span></p>
<p style="top:496.7pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">mental imagery) [29]. The authors interpreted this as</span></p>
<p style="top:508.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">an improvement in executive function.</span></p>
<p style="top:520.6pt;left:64.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">There was substantial variety in the intensity, mode</span></p>
<p style="top:532.7pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and duration of the exercise interventions in these four</span></p>
<p style="top:544.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">studies. One study included an exercise intervention in-</span></p>
<p style="top:556.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">volving low-intensity passive cycling once per week for</span></p>
<p style="top:568.7pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">four weeks. Another study included moderate-to-high</span></p>
<p style="top:580.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">intensity anabolic and aerobic exercise 60 minutes per</span></p>
<p style="top:592.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">session twice per week for 12 weeks. The intensity and</span></p>
<p style="top:604.7pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">the work load of the sessions were increased over time.</span></p>
<p style="top:616.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Each session involved a short low-intensity aerobic</span></p>
<p style="top:628.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">warm-up, six resistance exercises for both upper and</span></p>
<p style="top:640.7pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">lower body muscle groups, and then 25</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x2013;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">30 minutes of</span></p>
<p style="top:652.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">aerobic exercise on a stationary bicycle, rowing machine</span></p>
<p style="top:664.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">or treadmill. A third study included moderate-intensity</span></p>
<p style="top:676.7pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">multimodal exercise training involving aerobic exercise</span></p>
<p style="top:688.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">with the addition of resistance, coordination and balance</span></p>
<p style="top:700.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">training 60 minutes per session, three times per week for</span></p>
<p style="top:712.7pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">24 weeks. The 24-week intervention was divided into six</span></p>
<p style="top:724.6pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">phases and the load was increased after each phase. A</span></p>
<p style="top:328.6pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">session included five components: warm-up, stretching</span></p>
<p style="top:340.6pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">before exercise, exercise, cool-down, and stretching after</span></p>
<p style="top:352.7pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">exercise. The fourth study on tango implemented a stan-</span></p>
<p style="top:364.6pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">dardized structured tango program for 90-minute ses-</span></p>
<p style="top:376.6pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">sions twice per week for 12 weeks.</span></p>
<p style="top:388.7pt;left:312.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Further details of study characteristics and results for</span></p>
<p style="top:400.6pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">clinical studies are summarized in Tables 4 and 5.</span></p>
<p style="top:425.4pt;left:304.7pt;line-height:9.2pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:9.2pt">Major sources of risk of bias for clinical studies</span></p>
<p style="top:436.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Most of the studies had a selection bias from not ad-</span></p>
<p style="top:448.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">equately standardizing control subjects. More specifically,</span></p>
<p style="top:460.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">the subjects</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x2019;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> physical fitness levels and their concomitant</span></p>
<p style="top:472.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">medications before and during the study period were not</span></p>
<p style="top:484.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">documented and may have impacted their ability to exer-</span></p>
<p style="top:496.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cise and the ability to compare their potential benefits on</span></p>
<p style="top:508.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cognition. Additionally, information bias resulted from</span></p>
<p style="top:520.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">variability with the timing and intensity of the exercise</span></p>
<p style="top:532.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">intervention between subjects. Individuals may have</span></p>
<p style="top:544.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">received different amounts and types of exercise</span></p>
<p style="top:556.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">which could have affected the impact of exercise on</span></p>
<p style="top:568.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cognition.</span></p>
<p style="top:580.9pt;left:312.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Of the five randomized controlled clinical trials, four</span></p>
<p style="top:592.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">studies included control groups that received the same</span></p>
<p style="top:604.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">social interaction as the exercise intervention group.</span></p>
<p style="top:616.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">One study [26] included a control group receiving usual</span></p>
<p style="top:628.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">care, which did not control for the potential benefits to</span></p>
<p style="top:640.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">the subjects</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x2019;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> mood and cognition from increased social</span></p>
<p style="top:652.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">interaction through participation in the exercise inter-</span></p>
<p style="top:664.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">vention. Overall, both the pre-clinical and clinical stud-</span></p>
<p style="top:676.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ies showed a trend of selective reporting for only</span></p>
<p style="top:688.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">significant outcomes. A risk of bias across studies in-</span></p>
<p style="top:700.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cludes a publication bias, as studies with insignificant or</span></p>
<p style="top:712.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">negative findings are less likely to be published. The risk</span></p>
<p style="top:724.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">of bias for each clinical study is summarized in Table 5.</span></p>
<p style="top:89.3pt;left:56.7pt;line-height:9.0pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:9.0pt">Table 3 Quality of the evidence and strength of recommendations for human clinical trials</span><sup><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:6.4pt">1</span></sup></p>
<p style="top:103.2pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RgyhpyAdvTT83913201.I,serif;font-size:8.0pt">Study</span></p>
<p style="top:103.2pt;left:198.9pt;line-height:8.0pt"><span style="font-family:RgyhpyAdvTT83913201.I,serif;font-size:8.0pt">Can exercise improve a marker of</span></p>
<p style="top:112.3pt;left:198.9pt;line-height:8.0pt"><span style="font-family:RgyhpyAdvTT83913201.I,serif;font-size:8.0pt">cognitive function?</span></p>
<p style="top:103.2pt;left:341.5pt;line-height:8.0pt"><span style="font-family:RgyhpyAdvTT83913201.I,serif;font-size:8.0pt">Quality of evidence</span><sup><span style="font-family:RgyhpyAdvTT83913201.I,serif;font-size:5.7pt">2</span></sup></p>
<p style="top:103.2pt;left:438.6pt;line-height:8.0pt"><span style="font-family:RgyhpyAdvTT83913201.I,serif;font-size:8.0pt">Strength of recommendation</span><sup><span style="font-family:RgyhpyAdvTT83913201.I,serif;font-size:5.7pt">3</span></sup></p>
<p style="top:125.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Studies that specifically measured executive function (n = 4)</span></p>
<p style="top:139.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">McKee et al. 2013 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">29</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:139.4pt;left:198.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:139.4pt;left:341.5pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Moderate</span></p>
<p style="top:139.4pt;left:438.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Strong</span></p>
<p style="top:153.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Cruise et al. 2011 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">26</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:153.4pt;left:198.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:153.4pt;left:341.5pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Moderate</span></p>
<p style="top:153.4pt;left:438.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Strong</span></p>
<p style="top:167.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Ridgel et al. 2011 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">28</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:167.4pt;left:198.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:167.4pt;left:341.5pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Moderate</span></p>
<p style="top:167.4pt;left:438.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Strong</span></p>
<p style="top:181.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Tanaka et al. 2009 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">27</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:181.4pt;left:198.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:181.4pt;left:341.5pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Moderate</span></p>
<p style="top:181.4pt;left:438.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Strong</span></p>
<p style="top:195.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Studies that measured unspecified aspects of cognition (n = 4)</span></p>
<p style="top:209.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Dos Santos Mendes et al. 2012 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">25</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:209.4pt;left:198.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:209.4pt;left:341.5pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Low</span></p>
<p style="top:209.4pt;left:438.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Weak</span></p>
<p style="top:223.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Pompeu et al. 2012 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">24</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:223.4pt;left:198.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:223.4pt;left:341.5pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Low</span></p>
<p style="top:223.4pt;left:438.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Weak</span></p>
<p style="top:237.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">M&#xfc;ller et al. 2010 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">23</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:237.4pt;left:198.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:237.4pt;left:341.5pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Low</span></p>
<p style="top:237.4pt;left:438.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Weak</span></p>
<p style="top:251.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Baatile et al. 2000 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">22</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:251.4pt;left:198.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:251.4pt;left:341.5pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Low</span></p>
<p style="top:251.4pt;left:438.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Weak</span></p>
<p style="top:263.9pt;left:56.7pt;line-height:4.9pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:4.9pt">1</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.0pt">Quality of evidence and strength of recommendations based on the Grades of Recommendations, Assessment, Development, and Evaluation (GRADE) ranking</span></p>
<p style="top:273.8pt;left:56.7pt;line-height:7.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.0pt">system [</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.0pt">32</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.0pt">,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.0pt">33</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.0pt">].</span></p>
<p style="top:280.9pt;left:56.7pt;line-height:4.9pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:4.9pt">2</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.0pt">The GRADE system offers four levels of evidence: high, moderate, low and very low.</span></p>
<p style="top:289.4pt;left:56.7pt;line-height:4.9pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:4.9pt">3</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.0pt">The GRADE system offers three levels for the strength of a recommendation: strong, weak, or no recommendation.</span></p>
<p style="top:34.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Murray</span><span style="font-family:QcghtbAdvTT7329fd89.I,serif;font-size:8.0pt"> et al. Translational Neurodegeneration</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt"> 2014,</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:8.0pt"> 3</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">:5</span></p>
<p style="top:34.0pt;left:496.1pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Page 7 of 13</span></p>
<p style="top:44.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">http://www.translationalneurodegeneration.com/content/3/1/5</span></p>


<p style="top:592.5pt;left:56.7pt;line-height:10.3pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:10.3pt">Discussion</span></p>
<p style="top:605.3pt;left:56.7pt;line-height:9.2pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:9.2pt">Pre-clinical evidence</span></p>
<p style="top:616.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">The rodent studies identified in this review have sug-</span></p>
<p style="top:628.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">gested potential mechanisms for the benefits of exercise</span></p>
<p style="top:640.8pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">on cognitive improvements in PD, particularly related to</span></p>
<p style="top:652.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">learning and memory. The mechanisms include:</span></p>
<p style="top:676.8pt;left:64.7pt;line-height:9.8pt"><span style="font-family:VkbrmpAdvTT43ccf47d,serif;font-size:9.8pt">1) enhanced availability of DA in projections to the</span></p>
<p style="top:688.9pt;left:76.3pt;line-height:9.8pt"><span style="font-family:VkbrmpAdvTT43ccf47d,serif;font-size:9.8pt">dorsal and/or ventral striatum;</span></p>
<p style="top:700.9pt;left:64.7pt;line-height:9.8pt"><span style="font-family:VkbrmpAdvTT43ccf47d,serif;font-size:9.8pt">2) enhanced expression of neurotrophic factors BDNF</span></p>
<p style="top:712.8pt;left:76.3pt;line-height:9.8pt"><span style="font-family:VkbrmpAdvTT43ccf47d,serif;font-size:9.8pt">and GDNF, which could promote plasticity for</span></p>
<p style="top:724.9pt;left:76.3pt;line-height:9.8pt"><span style="font-family:VkbrmpAdvTT43ccf47d,serif;font-size:9.8pt">learning and memory; and</span></p>
<p style="top:592.9pt;left:312.7pt;line-height:9.8pt"><span style="font-family:VkbrmpAdvTT43ccf47d,serif;font-size:9.8pt">3) decreased oxidative stress and/or neuroinflammation</span></p>
<p style="top:604.8pt;left:324.3pt;line-height:9.8pt"><span style="font-family:VkbrmpAdvTT43ccf47d,serif;font-size:9.8pt">in the basal ganglia.</span></p>
<p style="top:628.9pt;left:312.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Two of the five studies that assessed biomarkers did not</span></p>
<p style="top:640.8pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">find effects from exercise following toxin administration.</span></p>
<p style="top:652.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">However, in one case forced and voluntary exercise</span></p>
<p style="top:664.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">similarly elevated striatal DA in both MPTP- and</span></p>
<p style="top:676.8pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">saline-treated groups, although there was no diffe-</span></p>
<p style="top:688.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">rence compared to sedentary saline-treated controls</span></p>
<p style="top:700.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">[17]. The other study used a model of chronic PD</span></p>
<p style="top:712.8pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">where the toxin was administered with probenecid</span></p>
<p style="top:724.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">over five weeks; while exercise restored regular motor</span></p>
<p style="top:89.3pt;left:56.7pt;line-height:9.0pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:9.0pt">Table 4 Study characteristics of clinical trials on human Parkinson</span><span style="font-family:KgvwbyAdvTTaf7f9f4f.B+20,serif;font-size:9.0pt">&#x2019;</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:9.0pt">s disease</span></p>
<p style="top:103.2pt;left:56.7pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Authors</span></p>
<p style="top:103.2pt;left:136.9pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Study title</span></p>
<p style="top:103.2pt;left:280.6pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Subjects</span></p>
<p style="top:103.2pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Intervention</span></p>
<p style="top:103.2pt;left:486.9pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Study design</span></p>
<p style="top:116.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Studies that specifically measured executive function (n = 4)</span></p>
<p style="top:130.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">McKee et al. 2013 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">29</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:130.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">The Effects of Adapted Tango on Spatial</span></p>
<p style="top:139.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Cognition and Disease Severity in</span></p>
<p style="top:148.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Parkinson</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2019;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">s Disease</span></p>
<p style="top:130.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Total n = 33 PD</span></p>
<p style="top:130.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Tango or education lessons</span></p>
<p style="top:130.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Randomized</span></p>
<p style="top:139.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">controlled trial</span></p>
<p style="top:144.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> n = 15 tango</span></p>
<p style="top:144.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Sessions 90 minutes long, 20 sessions over</span></p>
<p style="top:153.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">12 weeks, follow-up after 10</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">12 weeks</span></p>
<p style="top:158.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> n = 13 control</span></p>
<p style="top:172.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Cruise et al. 2011 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">26</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:172.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Exercise and Parkinson&apos;s: benefits for</span></p>
<p style="top:181.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">cognition and quality of life</span></p>
<p style="top:172.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Total n = 28 PD</span></p>
<p style="top:172.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Moderate-to-high-intensity anabolic and</span></p>
<p style="top:181.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">aerobic exercise or usual care</span></p>
<p style="top:172.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Single-blind</span></p>
<p style="top:181.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">randomized</span></p>
<p style="top:190.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">controlled trial</span></p>
<p style="top:186.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> n = 15 exercise</span></p>
<p style="top:200.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> n = 13 control</span></p>
<p style="top:200.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Sessions 1 hr/day, 2x/week for 12 weeks</span></p>
<p style="top:214.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Ridgel et al. 2011 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">28</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:214.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Changes in executive function after acute</span></p>
<p style="top:223.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">bouts of passive cycling in Parkinson&apos;s</span></p>
<p style="top:232.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">disease</span></p>
<p style="top:214.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Total n = 19 PD</span></p>
<p style="top:214.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Low-intensity passive aerobic exercise</span></p>
<p style="top:223.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">(cycling)</span></p>
<p style="top:214.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Randomized</span></p>
<p style="top:223.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">controlled trial,</span></p>
<p style="top:232.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">cross-over</span></p>
<p style="top:237.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Sessions 1/week for 4 weeks</span></p>
<p style="top:251.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Tanaka et al. 2009 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">27</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:251.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Benefits of physical exercise on executive</span></p>
<p style="top:260.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">functions in older people with Parkinson&apos;s</span></p>
<p style="top:269.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">disease</span></p>
<p style="top:251.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Total n = 20 PD</span></p>
<p style="top:251.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Moderate-intensity multimodal exercise</span></p>
<p style="top:260.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">training (aerobic, resistance, coordination</span></p>
<p style="top:269.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">and balance) or usual care</span></p>
<p style="top:251.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Controlled trial</span><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:5.7pt">*</span></sup></p>
<p style="top:265.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> n = 10 exercise</span></p>
<p style="top:279.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> n = 10 control</span></p>
<p style="top:283.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Sessions 1 hr/day, 3x/week for 24 weeks,</span></p>
<p style="top:292.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">intensity increased every 4 weeks</span></p>
<p style="top:306.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Studies that measured unspecified aspects of cognition (n = 4)</span></p>
<p style="top:320.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Dos Santos Mendes</span></p>
<p style="top:329.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">et al. 2012 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">25</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:320.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Motor learning, retention and transfer after</span></p>
<p style="top:329.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">virtual-reality-based training in Parkinson&apos;s</span></p>
<p style="top:338.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">disease - effect of motor and cognitive</span></p>
<p style="top:347.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">demands of games: a longitudinal,</span></p>
<p style="top:356.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">controlled clinical study</span></p>
<p style="top:320.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Total n = 27</span></p>
<p style="top:320.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Low-intensity Wii Fit</span><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:5.7pt">TM</span></sup><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> </span></sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">training, involving</span></p>
<p style="top:329.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">motor shifts and cognitive skills</span></p>
<p style="top:320.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Longitudinal</span></p>
<p style="top:329.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">pre-post trial</span></p>
<p style="top:334.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> n = 16 PD</span></p>
<p style="top:348.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> n = 11 healthy</span></p>
<p style="top:357.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">control</span></p>
<p style="top:348.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Sessions 1 hr/day, 2x/week for 7 weeks,</span></p>
<p style="top:357.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">follow-up at 60 days</span></p>
<p style="top:371.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Pompeu et al. 2012</span></p>
<p style="top:380.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">[</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">24</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:371.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Effect of Nintendo Wii</span><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:5.7pt">TM</span></sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">-based motor and</span></p>
<p style="top:380.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">cognitive training on activities of daily</span></p>
<p style="top:389.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">living in patients with Parkinson&apos;s disease:</span></p>
<p style="top:398.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">A randomised clinical trial</span></p>
<p style="top:371.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Total n = 32 PD</span></p>
<p style="top:371.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Both groups: low-intensity stretching,</span></p>
<p style="top:380.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">strengthening</span></p>
<p style="top:371.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Single-blind</span></p>
<p style="top:380.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">randomized</span></p>
<p style="top:389.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">controlled trial</span></p>
<p style="top:385.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> n = 16 exercise</span></p>
<p style="top:394.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">&amp; Wii</span></p>
<p style="top:394.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Experimental group: Wii Fit</span><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:5.7pt">TM</span></sup><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> </span></sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">-based</span></p>
<p style="top:408.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> n = 16 exercise</span><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">motor/cognitive training</span></sup></p>
<p style="top:417.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">no Wii</span></p>
<p style="top:417.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Control group: balance exercises without</span></p>
<p style="top:426.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">feedback or cognitive stimulation</span></p>
<p style="top:440.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Sessions 1 hr/day, 2x/wk for 7 weeks,</span></p>
<p style="top:449.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">follow-up at 60 days</span></p>
<p style="top:463.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">M&#xfc;ller et al. 2010 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">23</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:463.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Effect of exercise on reactivity and motor</span></p>
<p style="top:472.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">behaviour in patients with Parkinson&apos;s</span></p>
<p style="top:481.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">disease</span></p>
<p style="top:463.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Total n = 22 PD</span></p>
<p style="top:463.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Single bout of high-intensity endurance</span></p>
<p style="top:472.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">aerobic exercise (heart rate-targeted cycling)</span></p>
<p style="top:481.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">or rest following L-dopa administration</span></p>
<p style="top:463.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Randomized</span></p>
<p style="top:472.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">controlled</span></p>
<p style="top:481.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">feasibility trial,</span></p>
<p style="top:490.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">cross-over</span></p>
<p style="top:495.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Randomized order 1 day apart</span></p>
<p style="top:509.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Baatile et al. 2000 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">22</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:509.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Effect of exercise on perceived quality of</span></p>
<p style="top:518.4pt;left:136.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">life of individuals with Parkinson&apos;s disease</span></p>
<p style="top:509.4pt;left:280.6pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Total n = 6 PD</span></p>
<p style="top:509.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Low-intensity aerobic exercise program</span></p>
<p style="top:518.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">with Nordic walking poles (</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">PoleStriding</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">)</span></p>
<p style="top:509.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Nonrandomized</span></p>
<p style="top:518.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">feasibility trial,</span></p>
<p style="top:527.4pt;left:486.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">no control</span></p>
<p style="top:532.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Sessions 3x/week for 8 weeks</span></p>
<p style="top:546.4pt;left:56.7pt;line-height:7.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.0pt">*Subjects were assigned into the training group based on previous participation as a control in another study and upon referral by their physician. Baseline</span></p>
<p style="top:554.9pt;left:56.7pt;line-height:7.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.0pt">characteristics did not differ between the groups.</span></p>
<p style="top:34.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Murray</span><span style="font-family:QcghtbAdvTT7329fd89.I,serif;font-size:8.0pt"> et al. Translational Neurodegeneration</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt"> 2014,</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:8.0pt"> 3</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">:5</span></p>
<p style="top:34.0pt;left:496.1pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Page 8 of 13</span></p>
<p style="top:44.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">http://www.translationalneurodegeneration.com/content/3/1/5</span></p>


<p style="top:688.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">function, it had no effect on learning [20]. DA levels</span></p>
<p style="top:700.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">following the chronic toxin administration were low</span></p>
<p style="top:712.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and potentially more difficult to increase with exercise</span></p>
<p style="top:724.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">due to the substantial neurodegeneration.</span></p>
<p style="top:688.9pt;left:312.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">The obvious caveat to all studies using rodents to</span></p>
<p style="top:700.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">assess cognition is that the tasks of cognition, learn-</span></p>
<p style="top:712.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ing and memory require motor function to evaluate</span></p>
<p style="top:724.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">their performance. The models used in these studies</span></p>
<p style="top:89.3pt;left:56.7pt;line-height:9.0pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:9.0pt">Table 5 Outcomes and risk of bias of clinical trials on human Parkinson</span><span style="font-family:KgvwbyAdvTTaf7f9f4f.B+20,serif;font-size:9.0pt">&#x2019;</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:9.0pt">s disease</span></p>
<p style="top:103.2pt;left:56.7pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Study</span></p>
<p style="top:103.2pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Behavioral outcomes</span></p>
<p style="top:103.2pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:8.0pt">Major sources of risk of bias</span></p>
<p style="top:116.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Studies that specifically measured executive function (n = 4)</span></p>
<p style="top:130.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">McKee et al. 2013 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">29</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:130.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Tango improved disease severity (UPDRS-III)</span></p>
<p style="top:139.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">and spatial cognition/mental imagery (Brooks Spatial</span></p>
<p style="top:148.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Task) more than education group, maintained</span></p>
<p style="top:157.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">gains 10</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">12 weeks post-intervention</span></p>
<p style="top:130.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Detection bias: study was underpowered</span></p>
<p style="top:139.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">(n = 23 tango, n = 8 education) to evaluate</span></p>
<p style="top:148.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">some main effects within groups, so main</span></p>
<p style="top:157.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">effect of time was evaluated</span></p>
<p style="top:171.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Cruise et al. 2011 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">26</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:171.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Exercise improved verbal fluency and spatial working</span></p>
<p style="top:180.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">memory on Cambridge Neuropsychological Test</span></p>
<p style="top:189.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Automated Battery</span></p>
<p style="top:171.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Selection bias: the control group received</span></p>
<p style="top:180.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">usual care, no control for the effect of social</span></p>
<p style="top:189.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">interaction with exercise</span></p>
<p style="top:203.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Exercise was of</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt"> &#x201c;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">possible benefit</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x201d;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> on semantic</span></p>
<p style="top:212.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">fluency and mood</span></p>
<p style="top:203.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Information bias: the variable intensity level</span></p>
<p style="top:212.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">of the intervention could have affected</span></p>
<p style="top:221.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">outcomes</span></p>
<p style="top:226.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Exercise did not benefit spatial or pattern recognition,</span></p>
<p style="top:235.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">quality of life, had no negative impact</span></p>
<p style="top:249.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Ridgel et al. 2011 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">28</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:249.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Time to complete Trail Making Test A &amp; B (tests executive</span></p>
<p style="top:258.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">function) decreased after passive cycling</span></p>
<p style="top:249.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Selection bias: no control</span></p>
<p style="top:263.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Information bias: the same test pattern was</span></p>
<p style="top:272.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">used pre- and post-intervention, although</span></p>
<p style="top:281.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">practice effects were attempted to be</span></p>
<p style="top:290.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">controlled through pre-test training with</span></p>
<p style="top:299.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">the task</span></p>
<p style="top:272.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Performance improved on Trail Making Test B following</span></p>
<p style="top:281.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">passive cycling</span></p>
<p style="top:313.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Tanaka et al. 2009 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">27</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:313.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Exercise improved executive function for</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt"> &#x201c;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Categories</span></p>
<p style="top:322.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Completed</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x201d;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> (i.e., capacity for abstraction) and</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt"> &#x201c;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Preservative</span></p>
<p style="top:331.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Errors</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x201d;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> (i.e., mental flexibility) on the Wisconsin Card</span></p>
<p style="top:340.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Sorting Task</span></p>
<p style="top:313.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Selection bias: small sample size, no long-term</span></p>
<p style="top:322.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">follow-up, not purely randomized</span></p>
<p style="top:336.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Information bias: no mention of medication</span></p>
<p style="top:345.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">administration; only one participant in the group</span></p>
<p style="top:354.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">had a heart rate monitor, so the intensity was</span></p>
<p style="top:363.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">targeted towards the group and not the</span></p>
<p style="top:372.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">individual</span></p>
<p style="top:354.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> No interactions for confounding variables: concentrated</span></p>
<p style="top:363.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">attention, trait or state anxiety, depression</span></p>
<p style="top:386.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:8.0pt">Studies that measured unspecified aspects of cognition (n = 4)</span></p>
<p style="top:400.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Dos Santos Mendes et al. 2012 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">25</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:400.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> PD showed no deficit in learning or retention on 7/10</span></p>
<p style="top:409.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">games, deficits related to cognitive demands of tasks</span></p>
<p style="top:400.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Selection bias: the baseline physical fitness of</span></p>
<p style="top:409.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">the subjects was not compared</span></p>
<p style="top:423.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> PD had worse performance than healthy individuals on</span></p>
<p style="top:432.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">5 tests</span></p>
<p style="top:423.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Performance bias: no PD controls not performing</span></p>
<p style="top:432.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">intervention, no control for enjoyment or</span></p>
<p style="top:441.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">motivation</span></p>
<p style="top:446.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> PD could transfer learning to an untrained motor task at</span></p>
<p style="top:455.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">follow-up</span></p>
<p style="top:469.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Pompeu et al. 2012 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">24</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:469.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Both groups improved UPDRS-II, MoCA and balance, no</span></p>
<p style="top:478.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">additional advantage from Wii Fit</span><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:5.7pt">TM</span></sup></p>
<p style="top:469.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Information bias: the baseline physical fitness</span></p>
<p style="top:478.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">of the subjects was not compared, so potential</span></p>
<p style="top:487.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">for differences between groups</span></p>
<p style="top:492.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Improved scores on Wii Fit</span><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:5.7pt">TM</span></sup><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> </span></sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">games, maintained at</span></p>
<p style="top:501.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">follow-up</span></p>
<p style="top:515.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> No differences in outcomes between groups pre- to</span></p>
<p style="top:524.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">post-intervention or in follow-up</span></p>
<p style="top:538.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">M&#xfc;ller et al. 2010 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">23</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:538.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Reaction time increased after rest and decreased after</span></p>
<p style="top:547.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">exercise, movement time decreased after exercise</span></p>
<p style="top:538.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Selection bias: no PD control group, no healthy</span></p>
<p style="top:547.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">controls</span></p>
<p style="top:561.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Information bias: one-day washout period</span></p>
<p style="top:570.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">(24 hours) may not have been long enough; pilot trial</span></p>
<p style="top:561.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Number of correct answers decreased after rest</span></p>
<p style="top:574.8pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Tapping rate increased after exercise</span></p>
<p style="top:584.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Detection bias: unclear how reactivity was</span></p>
<p style="top:593.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">measured</span></p>
<p style="top:589.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Peg insertion interval time decreased after exercise</span></p>
<p style="top:598.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">(complex movement sequences, visual and spatial</span></p>
<p style="top:607.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">cognition, sorting and planning)</span></p>
<p style="top:621.4pt;left:56.7pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">Baatile et al. 2000 [</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">22</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:621.4pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Improved UPDRS score (only total score significant)</span></p>
<p style="top:621.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Selection bias: limited sample size, no control</span></p>
<p style="top:630.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">group; pilot trial</span></p>
<p style="top:634.8pt;left:178.0pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Improved PDQ-39 score, most improved in cognition</span></p>
<p style="top:643.8pt;left:178.0pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">component</span></p>
<p style="top:644.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:8.0pt">&#x2022;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt"> Information bias: exercise intensity not</span></p>
<p style="top:653.4pt;left:375.9pt;line-height:8.0pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:8.0pt">standardized</span></p>
<p style="top:34.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Murray</span><span style="font-family:QcghtbAdvTT7329fd89.I,serif;font-size:8.0pt"> et al. Translational Neurodegeneration</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt"> 2014,</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:8.0pt"> 3</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">:5</span></p>
<p style="top:34.0pt;left:496.1pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Page 9 of 13</span></p>
<p style="top:44.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">http://www.translationalneurodegeneration.com/content/3/1/5</span></p>


<p style="top:88.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">(i.e., MPTP, 6-OHDA and reserpine) are widely ac-</span></p>
<p style="top:100.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cepted, although none of them recapitulates the indo-</span></p>
<p style="top:112.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">lent</span></p>
<p style="top:112.9pt;left:80.4pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and</span></p>
<p style="top:112.9pt;left:103.5pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">progressive</span></p>
<p style="top:112.9pt;left:158.1pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">nature</span></p>
<p style="top:112.9pt;left:192.8pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">of</span></p>
<p style="top:112.9pt;left:208.8pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">PD</span></p>
<p style="top:112.9pt;left:229.4pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">[35-40].</span></p>
<p style="top:112.9pt;left:269.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">It</span></p>
<p style="top:124.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">unknown how the time of onset or intensity of the</span><sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">is</span></sup></p>
<p style="top:136.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">exercise paradigm initiated during or following the le-</span></p>
<p style="top:148.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">sion/toxin may affect the severity of parkinsonism.</span></p>
<p style="top:160.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">More promising models for the future would include</span></p>
<p style="top:172.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">transgenic or knock-in rodents characterized by ex-</span></p>
<p style="top:184.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">pression of mutant or overexpression of wild-type</span><span style="font-family:VvtxvxAdvTT86d47313+03,serif;font-size:9.8pt"> &#x3b1;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">-</span></p>
<p style="top:196.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">synuclein. A related model is the injection of syn-</span></p>
<p style="top:208.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">thetic</span><span style="font-family:VvtxvxAdvTT86d47313+03,serif;font-size:9.8pt"> &#x3b1;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">-synuclein fibrils into the rodent brain. This</span></p>
<p style="top:220.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">model shows progressive and selective loss of DA</span></p>
<p style="top:232.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">neurons in the substantia nigra pars compacta, as</span></p>
<p style="top:244.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">well as cell-to-cell transmission in anatomically con-</span></p>
<p style="top:256.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">nected regions [41]. As cortical Lewy body pathology</span></p>
<p style="top:268.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">is a major contributing factor to dementia in PD [42],</span></p>
<p style="top:280.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">future research with models of abnormal</span><span style="font-family:VvtxvxAdvTT86d47313+03,serif;font-size:9.8pt"> &#x3b1;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">-synuclein</span></p>
<p style="top:292.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">deposition may translate better into clinical research</span></p>
<p style="top:304.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and practice than models that create basal ganglia</span></p>
<p style="top:316.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">lesions.</span></p>
<p style="top:328.9pt;left:64.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">The potential for exercise to improve cognition by re-</span></p>
<p style="top:340.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ducing the impact of neuroinflammation is promising.</span></p>
<p style="top:352.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Another study in a rodent model not dependent upon a</span></p>
<p style="top:364.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">selective dopaminergic neurotoxin found that forced</span></p>
<p style="top:376.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">treadmill and voluntary wheel exercise in rats can also</span></p>
<p style="top:388.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">alleviate impairments from brain inflammation on long-</span></p>
<p style="top:400.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">term potentiation and spatial learning [43]. The authors</span></p>
<p style="top:412.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">injected rats with lipopolysaccharides into the cerebral</span></p>
<p style="top:424.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ventricles to induce brain inflammation. They found that</span></p>
<p style="top:436.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">both treadmill and wheel training improved the resulting</span></p>
<p style="top:448.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">deterioration in spatial learning. The effects of exercise</span></p>
<p style="top:460.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">on learning were attributed to enhanced expression of</span></p>
<p style="top:472.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">BDNF, tyrosine kinase B and phosphorylated cyclic AMP</span></p>
<p style="top:484.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">response element binding protein in the hippocampus.</span></p>
<p style="top:496.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">The impact of the injection on neuroinflammation was</span></p>
<p style="top:508.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">not documented. This model results in preferential but</span></p>
<p style="top:520.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">not entirely selective nigral DA cell degeneration and</span></p>
<p style="top:532.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">the findings may thus provide insight into potential</span></p>
<p style="top:544.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">mechanisms of exercise in humans to reduce brain in-</span></p>
<p style="top:556.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">flammation and improve cognition.</span></p>
<p style="top:568.9pt;left:64.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Overall, the results from these studies on rodent models</span></p>
<p style="top:580.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">of PD offer promising support for exercise to improve</span></p>
<p style="top:592.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cognition in humans with PD through the promotion of</span></p>
<p style="top:604.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">neuronal proliferation, neuroprotection, neurogenesis, and</span></p>
<p style="top:616.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">potentially reduction in brain inflammation. These results</span></p>
<p style="top:628.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">support recent work that highlights how exercise likely</span></p>
<p style="top:640.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">promotes neurorestoration through activation of signaling</span></p>
<p style="top:652.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cascades by neurotrophic factors [44]. Exercise has been</span></p>
<p style="top:664.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">shown to affect regulation of DA function, including up-</span></p>
<p style="top:676.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">regulated DA D</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:6.9pt">2</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> receptor mRNA and down-regulated</span></p>
<p style="top:688.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">striatal DAT in rodents [16]. High-intensity exercise also</span></p>
<p style="top:700.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">increased DA D</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:6.9pt">2</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> receptor availability in a recent feasibility</span></p>
<p style="top:712.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">study by the same group using five human subjects (n = 2</span></p>
<p style="top:724.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">PD exercise, n = 2 PD no exercise, n = 1 healthy control)</span></p>
<p style="top:88.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and positron emission tomography with [</span><sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:6.9pt">18</span></sup><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">F]fallypride</span></p>
<p style="top:100.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">[45]. While this small human trial does not assess cogni-</span></p>
<p style="top:112.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tion, these findings encourage more clinical trials based</span></p>
<p style="top:124.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">on rodent outcomes in this field. Overall, the evidence</span></p>
<p style="top:136.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">from rodent studies in this systematic review cannot be</span></p>
<p style="top:148.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">directly applied to mechanisms in humans yet, but they</span></p>
<p style="top:160.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">suggest that PD patients would likely experience a mean-</span></p>
<p style="top:172.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ingful improvement in cognition in response to exercise.</span></p>
<p style="top:197.4pt;left:304.7pt;line-height:9.2pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:9.2pt">Clinical evidence</span></p>
<p style="top:208.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Clinical studies in humans demonstrate that various mo-</span></p>
<p style="top:220.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">dalities and intensity levels of exercise can improve cog-</span></p>
<p style="top:232.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">nitive capacity in PD, and especially executive function,</span></p>
<p style="top:244.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">although the mechanisms have not yet been determined.</span></p>
<p style="top:256.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Cognitive dysfunction in PD is commonly associated</span></p>
<p style="top:268.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">with impaired executive function [46]. However, evaluat-</span></p>
<p style="top:280.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ing research on cognition, and particularly executive</span></p>
<p style="top:292.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">function, in PD is challenging because mild cognitive</span></p>
<p style="top:304.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">impairment (MCI) in PD has only recently been defined</span></p>
<p style="top:316.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and formal diagnostic criteria are still in development</span></p>
<p style="top:328.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">[47]. Selection and interpretation of measures of execu-</span></p>
<p style="top:340.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tive function in PD have been challenging and the clin-</span></p>
<p style="top:352.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ical implications are not yet fully appreciated [48].</span></p>
<p style="top:364.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Executive function is generally related to goal-directed</span></p>
<p style="top:376.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">behaviors processed by the frontal lobes of the brain. Ex-</span></p>
<p style="top:388.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ecutive function has been categorized into four compo-</span></p>
<p style="top:400.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">nents: planning, purposive action, effective performance</span></p>
<p style="top:412.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and volition [49]. It is not known what frequency, inten-</span></p>
<p style="top:424.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">sity, type or timing of exercise might be most effective</span></p>
<p style="top:436.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">to improve executive function in PD, but there is evi-</span></p>
<p style="top:448.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">dence in older adults without PD that light aerobic exer-</span></p>
<p style="top:460.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cise (walking), and not anaerobic exercise (stretching</span></p>
<p style="top:472.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and toning), selectively improves executive functions</span></p>
<p style="top:484.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">processed in the frontal and prefrontal areas of the brain</span></p>
<p style="top:496.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">[50]. The potential different effects of aerobic compared</span></p>
<p style="top:508.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">to anaerobic exercise on cognition in PD have not yet</span></p>
<p style="top:520.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">been studied.</span></p>
<p style="top:532.9pt;left:312.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Exercise in animal models of PD may induce DA re-</span></p>
<p style="top:544.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">lease and enhance DA transmission via up-regulation of</span></p>
<p style="top:556.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">DA D</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:6.9pt">2</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> receptors [51,52]. A systematic review on the ef-</span></p>
<p style="top:568.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">fects of exercise in the elderly showed that moderate-</span></p>
<p style="top:580.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">intensity exercise can effectively increase peripheral</span></p>
<p style="top:592.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">BDNF [53]. Serum BDNF crosses the blood</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x2013;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">brain bar-</span></p>
<p style="top:604.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">rier so these results may have implications for brain neu-</span></p>
<p style="top:616.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">rotrophin levels [54]. One of the animal studies reviewed</span></p>
<p style="top:628.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">in this paper also found that exercise increased BDNF</span></p>
<p style="top:640.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and GDNF in the striatum [18]. The findings from this</span></p>
<p style="top:652.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">review support the theory of potential neuroprotective</span></p>
<p style="top:664.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">benefits of exercise for human PD. A recent review on</span></p>
<p style="top:676.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">the benefit of exercise to improve cognition emphasized</span></p>
<p style="top:688.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">the potential neuroprotective effects of vigorous exercise</span></p>
<p style="top:700.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">in PD [13]. The authors provided guidelines including</span></p>
<p style="top:712.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">vigorous exercise, structured programs for cognitively</span></p>
<p style="top:724.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">impaired patients, and therapies that replenish DA to</span></p>
<p style="top:34.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Murray</span><span style="font-family:QcghtbAdvTT7329fd89.I,serif;font-size:8.0pt"> et al. Translational Neurodegeneration</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt"> 2014,</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:8.0pt"> 3</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">:5</span></p>
<p style="top:34.0pt;left:492.0pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Page 10 of 13</span></p>
<p style="top:44.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">http://www.translationalneurodegeneration.com/content/3/1/5</span></p>


<p style="top:88.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">provide the maximum capability and motivation to exer-</span></p>
<p style="top:100.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cise [13]. In addition to these guidelines, the current sys-</span></p>
<p style="top:112.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tematic review shows that any exercise should be</span></p>
<p style="top:124.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">encouraged as it may benefit numerous aspects of pa-</span></p>
<p style="top:136.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tients</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x2019;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> cognitive function and these effects could be</span></p>
<p style="top:148.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">transferrable to other tasks. Importantly, the effects of</span></p>
<p style="top:160.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">vigorous exercise can last up to 60 days [25,29]. In these</span></p>
<p style="top:172.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">studies there was overall a high retention rate for subjects</span></p>
<p style="top:184.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">committing to a twice or three times weekly exercise pro-</span></p>
<p style="top:196.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">gram, suggesting that these interventions could be feasibly</span></p>
<p style="top:208.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">implemented as treatment programs. A recent meta-</span></p>
<p style="top:220.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">analysis showed that very light to vigorous exercise seems</span></p>
<p style="top:232.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">to have a small effect on cognition in the acute phase fol-</span></p>
<p style="top:244.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">lowing exercise, but larger longer-lasting effects are pos-</span></p>
<p style="top:256.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">sible with more intense exercise [55].</span></p>
<p style="top:268.9pt;left:64.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">The benefits of exercise on cognition in PD are com-</span></p>
<p style="top:280.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">parable to those seen in healthy older adults. A recent</span></p>
<p style="top:292.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">review showed that endurance and resistance exercise</span></p>
<p style="top:304.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">can improve cognition in healthy seniors [7]. There is</span></p>
<p style="top:316.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">less research on the effects of exercise in frail older</span></p>
<p style="top:328.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">adults, but recent evidence showed that a three-month</span></p>
<p style="top:340.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">physical activity intervention improved physical abilities,</span></p>
<p style="top:352.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">executive functions, processing speed and working mem-</span></p>
<p style="top:364.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ory [56]. The effects of exercise on cognition in older</span></p>
<p style="top:376.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">adults with MCI are less promising, as a recent meta-</span></p>
<p style="top:388.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">analysis showed only limited potential to improve cogni-</span></p>
<p style="top:400.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tion [57]. However, the interpretation is constrained</span></p>
<p style="top:412.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">because many of the publications were deemed by the</span></p>
<p style="top:424.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">authors of this analysis to be of moderate quality and</span></p>
<p style="top:436.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">many of the studies were underpowered. It is possible</span></p>
<p style="top:448.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">that exercise may have an impact on dopaminergic sig-</span></p>
<p style="top:460.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">naling that renders it particularly valuable in PD.</span></p>
<p style="top:472.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Whether cognition in PD is improved due to dopa-</span></p>
<p style="top:484.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">minergic mechanisms of exercise or other mechanisms</span></p>
<p style="top:496.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">such as increased neurotrophic factor availability or</span></p>
<p style="top:508.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">reduced neuroinflammation remains to be determined.</span></p>
<p style="top:533.4pt;left:56.7pt;line-height:9.2pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:9.2pt">Limitations</span></p>
<p style="top:544.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Limitations at the level of each study include risk of in-</span></p>
<p style="top:556.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">formation, performance and/or selection biases (Tables 2</span></p>
<p style="top:568.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and 5) as well as confounds inherent with the limitations</span></p>
<p style="top:580.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">of non-randomized trials. There was overall a lack of</span></p>
<p style="top:592.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">reporting of concomitant medications (i.e., PD therapies</span></p>
<p style="top:604.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and antidepressants) as well as the medical condition of</span></p>
<p style="top:616.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">the subjects, which could have affected the results. The</span></p>
<p style="top:628.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">limitations of this review include potential for incom-</span></p>
<p style="top:640.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">plete retrieval of information given the search strategy</span></p>
<p style="top:652.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and inclusion criteria. Additionally, it is not known</span></p>
<p style="top:664.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">whether there are genetic factors underlying response to</span></p>
<p style="top:676.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">exercise in PD.</span></p>
<p style="top:700.5pt;left:56.7pt;line-height:10.3pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:10.3pt">Conclusions</span></p>
<p style="top:712.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Overall, this systematic review found that exercise can im-</span></p>
<p style="top:724.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">prove cognitive function in animal models and human PD.</span></p>
<p style="top:88.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Pre-clinical studies showed exercise results in behavioral</span></p>
<p style="top:100.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and corresponding neurobiological changes in the basal</span></p>
<p style="top:112.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ganglia related to cognition. Specifically, learning and</span></p>
<p style="top:124.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">memory improved after exercise in the rodents, although</span></p>
<p style="top:136.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">the exact mechanisms remain unclear and merit further re-</span></p>
<p style="top:148.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">search. Pre-clinical studies also showed that any exercise is</span></p>
<p style="top:160.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">better than inactivity and that forced exercise has a greater</span></p>
<p style="top:172.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">impact than self-paced voluntary exercise. Exercise resulted</span></p>
<p style="top:184.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">in structural, neurochemical and molecular changes in ro-</span></p>
<p style="top:196.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">dents, which may be of relevance to the human disorder.</span></p>
<p style="top:208.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">The clinical studies showed that various types of exercise,</span></p>
<p style="top:220.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">including aerobic, resistance and dance can improve cogni-</span></p>
<p style="top:232.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">tive function, especially executive function in PD patients.</span></p>
<p style="top:244.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">However, the best type, amount, mechanisms, and duration</span></p>
<p style="top:256.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">of exercise are not yet known. The evidence from clinical</span></p>
<p style="top:268.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">studies suggests that a more intensive aerobic exercise pro-</span></p>
<p style="top:280.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">gram including strength and balance training can promote</span></p>
<p style="top:292.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">greater cognitive gains. However, low-intensity exercise</span></p>
<p style="top:304.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">and balance-based exercises also showed benefits.</span></p>
<p style="top:316.9pt;left:312.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Research on the effects of exercise on cognition in PD</span></p>
<p style="top:328.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">is a relatively new area. As outlined in this review, there</span></p>
<p style="top:340.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">are several limitations with the current studies in terms</span></p>
<p style="top:352.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">of study design and risks of bias. Questions that remain</span></p>
<p style="top:364.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">to be addressed include the prescription of exercise, if</span></p>
<p style="top:376.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">any, which elicits the most gains as well as the duration</span></p>
<p style="top:388.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">of effects. Future research on the effects of exercise on</span></p>
<p style="top:400.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cognition in PD should include a longitudinal random-</span></p>
<p style="top:412.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ized controlled clinical trial examining neurobiological</span></p>
<p style="top:424.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">mechanisms</span><span style="font-family:MjdkrqAdvTT8861b38f.I,serif;font-size:9.8pt"> in vivo</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">, including neuroimaging. Under-</span></p>
<p style="top:436.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">standing the mechanism of benefit from exercise could</span></p>
<p style="top:448.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">help us to harness its potential neuroprotective effects.</span></p>
<p style="top:460.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Patients should use these findings as further rationale to</span></p>
<p style="top:472.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">increase their daily physical activity. With growing sup-</span></p>
<p style="top:484.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">port for exercise to improve not only motor symptoms,</span></p>
<p style="top:496.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">but also cognitive impairments in PD, health care pro-</span></p>
<p style="top:508.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">viders and policy makers should recommend exercise</span></p>
<p style="top:520.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">as part of routine management and neurorehabilitation</span></p>
<p style="top:532.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">for PD.</span></p>
<p style="top:556.5pt;left:304.7pt;line-height:10.3pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:10.3pt">Appendix</span></p>
<p style="top:569.4pt;left:304.7pt;line-height:9.2pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:9.2pt">Appendix 1: Methodology on information sources, study</span></p>
<p style="top:581.4pt;left:304.7pt;line-height:9.2pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:9.2pt">search and collection</span></p>
<p style="top:592.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">The following electronic databases were searched for ar-</span></p>
<p style="top:604.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ticles: PubMed, Web of Knowledge, and EBM Reviews</span></p>
<p style="top:616.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">(OvidSP). The primary search parameter for each data-</span></p>
<p style="top:628.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">base used the keywords,</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt"> &#x201c;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Parkinson</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x2019;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">s disease</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201d;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> AND</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt"> &#x201c;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ex-</span></p>
<p style="top:640.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ercise</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201d;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> AND</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt"> &#x201c;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cognition</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201d;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> with the Boolean operator</span></p>
<p style="top:652.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201c;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">AND</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201d;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">. Additional keywords related to cognition were</span></p>
<p style="top:664.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">also searched by replacing</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt"> &#x201c;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">cognition</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201d;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt"> in the primary</span></p>
<p style="top:676.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">keyword phrase one at a time with each of</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt"> &#x201c;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">dementia</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201d;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">,</span></p>
<p style="top:688.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201c;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">Alzheimer</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201d;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">,</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt"> &#x201c;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">memory</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201d;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">,</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt"> &#x201c;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">executive function</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201d;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">, and</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt"> &#x201c;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">im-</span></p>
<p style="top:700.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">pulse</span><span style="font-family:VpdhqpAdvTT86d47313+20,serif;font-size:9.8pt">&#x201d;</span><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">. Additional studies were identified by ancestry</span></p>
<p style="top:712.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">searches of the articles yielded from the electronic</span></p>
<p style="top:724.9pt;left:304.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">search. No limits were provided for any of the database</span></p>
<p style="top:34.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Murray</span><span style="font-family:QcghtbAdvTT7329fd89.I,serif;font-size:8.0pt"> et al. Translational Neurodegeneration</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt"> 2014,</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:8.0pt"> 3</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">:5</span></p>
<p style="top:34.0pt;left:492.0pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Page 11 of 13</span></p>
<p style="top:44.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">http://www.translationalneurodegeneration.com/content/3/1/5</span></p>


<p style="top:88.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">searches. Study author DM performed all aspects of the</span></p>
<p style="top:100.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">search, screen and identification of eligible studies (Figure 1).</span></p>
<p style="top:112.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">All studies identified through the information sources were</span></p>
<p style="top:124.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">compiled on the citation manager, EndNote. The titles of</span></p>
<p style="top:136.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">each study were then screened to identify PD participants,</span></p>
<p style="top:148.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">including human subjects or PD-like animal models. The</span></p>
<p style="top:160.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">abstracts of each remaining study were then searched manu-</span></p>
<p style="top:172.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ally for the eligibility criteria. The full text was searched for</span></p>
<p style="top:184.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">articles deemed to meet the eligibility criteria based on their</span></p>
<p style="top:196.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">title and abstract. All data were extracted by the study au-</span></p>
<p style="top:208.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">thor DM in their existing form from the articles. The col-</span></p>
<p style="top:220.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">lected data and risk of bias [32] was used to assess the</span></p>
<p style="top:232.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">clinical studies for their quality of the evidence and deter-</span></p>
<p style="top:244.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">mine the strength of the recommendations (Table 3) based</span></p>
<p style="top:256.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">on the Grades of Recommendations, Assessment, Develop-</span></p>
<p style="top:268.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">ment, and Evaluation (GRADE) ranking system [33]. The</span></p>
<p style="top:280.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">clinical studies were assigned the same GRADE rankings by</span></p>
<p style="top:292.9pt;left:56.7pt;line-height:9.8pt"><span style="font-family:CfwwjfAdvTT86d47313,serif;font-size:9.8pt">two independent raters (DM and MS).</span></p>
<p style="top:318.4pt;left:56.7pt;line-height:10.3pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:10.3pt">Additional file</span></p>
<p style="top:342.9pt;left:62.0pt;line-height:7.5pt"><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:7.5pt">Additional file 1:</span><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:7.5pt"> PRISMA Guidelines Checklist.</span></p>
<p style="top:368.1pt;left:56.7pt;line-height:7.5pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:7.5pt">Abbreviations</span></p>
<p style="top:377.1pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">MPTP:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt"> 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 5HT: Serotonin;</span></p>
<p style="top:386.1pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">6-OHDA: 6-hydroxydopamine; BDNF: Brain-derived neurotrophic factor;</span></p>
<p style="top:395.1pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">BDNF: Bromodeoxyuridine; DA: Dopamine; DAT: Dopamine transporter;</span></p>
<p style="top:404.1pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">EF: Executive function; GDNF: Glial cell-derived neurotrophic factor;</span></p>
<p style="top:413.1pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">L-dopa: Levodopa; LTP: Long-term potentiation; MCI: Mild cognitive</span></p>
<p style="top:422.1pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">impairment; MoCA: Montreal Cognitive Assessment; MPTP: 1-methyl-4-</span></p>
<p style="top:431.1pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">phenyl-1,2,3,6,-tetrahydropyridine; ORP: Overall Rotarod performance;</span></p>
<p style="top:440.1pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">PDQ-39: Parkinson</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.5pt">&#x2019;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">s Disease Questionnaire; PD: Parkinson</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.5pt">&#x2019;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">s disease;</span></p>
<p style="top:449.1pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">p-CREB: Phosphorylated cyclic AMP response binding protein;</span></p>
<p style="top:458.1pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">5HT: Serotonin; PDQ-39-SI: Parkinson</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.5pt">&#x2019;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">s Disease Questionnaire-39-Single</span></p>
<p style="top:467.1pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Index; TH: Tyrosine hydroxylase; TMT: Trail-Making Test; Trk-B: Tyrosine</span></p>
<p style="top:476.1pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">kinase B; UPDRS: Unified Parkinson</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.5pt">&#x2019;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">s Disease Rating Scale.</span></p>
<p style="top:496.0pt;left:56.7pt;line-height:7.5pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:7.5pt">Competing interests</span></p>
<p style="top:505.0pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">The authors declare that they have no competing interests.</span></p>
<p style="top:524.9pt;left:56.7pt;line-height:7.5pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:7.5pt">Authors</span><span style="font-family:TgpgkvAdvTT99c4c969+20,serif;font-size:7.5pt">&#x2019;</span><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:7.5pt"> contributions</span></p>
<p style="top:533.9pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">DM conducted all aspects of the literature search and primary preparation of</span></p>
<p style="top:542.9pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">this manuscript. All authors critically revised drafts of this manuscript, and</span></p>
<p style="top:551.9pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">read and approved the final manuscript.</span></p>
<p style="top:571.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:7.5pt">Authors</span><span style="font-family:TgpgkvAdvTT99c4c969+20,serif;font-size:7.5pt">&#x2019;</span><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:7.5pt"> information</span></p>
<p style="top:580.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Danielle K. Murray is a graduate student in the Graduate Program in</span></p>
<p style="top:589.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Neuroscience at the University of British Columbia.</span></p>
<p style="top:598.9pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Matthew A. Sacheli is a graduate student in the Graduate Program in</span></p>
<p style="top:607.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Neuroscience at the University of British Columbia.</span></p>
<p style="top:616.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Janice J. Eng is a Professor in the Department of Physical Therapy at the</span></p>
<p style="top:625.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">University of British Columbia.</span></p>
<p style="top:634.9pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">A. Jon Stoessl is a Canada Research Chair in Parkinson</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.5pt">&#x2019;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">s disease, Director of</span></p>
<p style="top:643.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">the Pacific Parkinson</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.5pt">&#x2019;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">s Research Centre and Professor and Head of Neurology</span></p>
<p style="top:652.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">at the University of British Columbia.</span></p>
<p style="top:672.7pt;left:56.7pt;line-height:7.5pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:7.5pt">Acknowledgement</span></p>
<p style="top:690.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:7.5pt">Funding</span></p>
<p style="top:699.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">This systematic review was not funded. AJS is supported by the Canada</span></p>
<p style="top:708.7pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Research Chairs, Canadian Institute of Health Research, Michael J. Fox</span></p>
<p style="top:717.7pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Foundation, Pacific Alzheimer Research Foundation and the Pacific</span></p>
<p style="top:726.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Parkinson</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.5pt">&#x2019;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">s Research Institute.</span></p>
<p style="top:90.8pt;left:304.7pt;line-height:7.5pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:7.5pt">Author details</span></p>
<p style="top:98.2pt;left:304.7pt;line-height:5.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:5.3pt">1</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Pacific Parkinson</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.5pt">&#x2019;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">s Research Centre and Department of Medicine, Division of</span></p>
<p style="top:108.7pt;left:304.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Neurology, University of British Columbia &amp; Vancouver Coastal Health,</span></p>
<p style="top:117.8pt;left:304.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Vancouver, BC V6T 2B5, Canada.</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:5.3pt"> </span><sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:5.3pt">2</span></sup><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">Department of Physical Therapy, University</span></p>
<p style="top:126.8pt;left:304.7pt;line-height:7.5pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.5pt">of British Columbia, Vancouver, BC V6T 1Z3, Canada.</span></p>
<p style="top:144.7pt;left:304.7pt;line-height:7.5pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.5pt">Received: 10 December 2013 Accepted: 14 February 2014</span></p>
<p style="top:153.8pt;left:304.7pt;line-height:7.5pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.5pt">Published: 24 February 2014</span></p>
<p style="top:186.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">1.</span><sup><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:7.5pt">References</span></sup></p>
<p style="top:186.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Aarsland D, Larsen JP, Lim NG, Janvin C, Karlsen K, Tandberg E, Cummings</span></p>
<p style="top:195.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">JL:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Range of neuropsychiatric disturbances in patients with Parkinson&apos;s</span></p>
<p style="top:204.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">disease.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> J Neurol Neurosurg Psychiatry</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 1999,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 67:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">492</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">496.</span></p>
<p style="top:213.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">2.</span></p>
<p style="top:213.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Chaudhuri KR, Healy DG, Schapira AHV:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Non-motor symptoms of</span></p>
<p style="top:222.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Parkinson&apos;s disease: diagnosis and management.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Lancet Neurol</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2006,</span></p>
<p style="top:231.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">5:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">235</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">245.</span></p>
<p style="top:240.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">3.</span></p>
<p style="top:240.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Macht M, Schwarz R, Ellgring H:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Patterns of psychological problems in</span></p>
<p style="top:249.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Parkinson&apos;s disease.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Acta neurologica Scandinavica</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2005,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 111:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">95</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">101.</span></p>
<p style="top:258.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">4.</span></p>
<p style="top:258.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Hely MA, Reid WGJ, Adena MA, Halliday GA, Morris JGL:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> The Sydney</span></p>
<p style="top:267.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">multicenter study of Parkinson&apos;s disease: the inevitability of dementia at</span></p>
<p style="top:276.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">20 years.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Mov Disord</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2008,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 23:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">837</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">844.</span></p>
<p style="top:285.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">5.</span></p>
<p style="top:285.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I,</span></p>
<p style="top:294.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Cummings JL, Chertkow H:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> The montreal cognitive assessment, MoCA: a</span></p>
<p style="top:303.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">brief screening tool for mild cognitive impairment.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> J Am Geriatr Soc</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2005,</span></p>
<p style="top:312.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">53:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">695</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">699.</span></p>
<p style="top:321.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">6.</span></p>
<p style="top:321.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Zadikoff C, Fox SH, Tang-Wai DF, Thomsen T, de Bie RMA, Wadia P, Miyasaki J,</span></p>
<p style="top:330.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Duff-Canning S, Lang AE, Marras C:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> A comparison of the mini mental state</span></p>
<p style="top:339.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">exam to the Montreal cognitive assessment in identifying cognitive deficits</span></p>
<p style="top:348.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">in Parkinson&apos;s disease.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Mov Disord</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2008,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 23:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">297</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">299.</span></p>
<p style="top:357.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">7.</span></p>
<p style="top:357.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Muller T, Kuhn W:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Cysteine elevation in levodopa-treated patients with</span></p>
<p style="top:366.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Parkinson&apos;s disease.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Mov Disord</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2009,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 24:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">929</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">932.</span></p>
<p style="top:375.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">8.</span></p>
<p style="top:375.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Tillerson JL, Caudle WM, Reveron ME, Miller GW:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Exercise induces</span></p>
<p style="top:384.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">behavioral recovery and attenuates neurochemical deficits in rodent</span></p>
<p style="top:393.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">models of Parkinson&apos;s disease.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Neuroscience</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2003,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 119:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">899</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">911.</span></p>
<p style="top:402.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">9.</span></p>
<p style="top:402.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Allen NE, Sherrington C, Paul SS, Canning CG:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Balance and falls in</span></p>
<p style="top:411.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Parkinson&apos;s disease: a meta-analysis of the effect of exercise and motor</span></p>
<p style="top:420.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">training.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Mov Disord</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2011,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 26:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">1605</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">1615.</span></p>
<p style="top:429.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">10.</span></p>
<p style="top:429.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Lauhoff P, Murphy N, Doherty C, Horgan NF:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> A controlled clinical trial</span></p>
<p style="top:438.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">investigating the effects of cycle ergometry training on exercise</span></p>
<p style="top:447.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">tolerance, balance and quality of life in patients with Parkinson&apos;s</span></p>
<p style="top:456.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">disease.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Disabil Rehabil</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2013,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 35:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">382</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">387.</span></p>
<p style="top:465.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">11.</span></p>
<p style="top:465.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Ridgel AL, Peacock CA, Fickes EJ, Kim CH:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Active-assisted cycling improves</span></p>
<p style="top:474.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Tremor and Bradykinesia in Parkinson&apos;s disease.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Arch Phys Med Rehabil</span></p>
<p style="top:483.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">2049</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">2054,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 2012:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">93.</span></p>
<p style="top:492.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">12.</span></p>
<p style="top:492.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Ridgel AL, Vitek JL, Alberts JL:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Forced, not voluntary, exercise improves</span></p>
<p style="top:501.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">motor function in Parkinson&apos;s disease patients.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Neurorehabil Neural Repair</span></p>
<p style="top:510.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">2009,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 23:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">600</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">608.</span></p>
<p style="top:519.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">13.</span></p>
<p style="top:519.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Ahlskog JE:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Does vigorous exercise have a neuroprotective effect in</span></p>
<p style="top:528.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Parkinson disease?</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Neurology</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2011,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 77:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">288</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">294.</span></p>
<p style="top:537.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">14.</span></p>
<p style="top:537.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Hindle JV, Petrelli A, Clare L, Kalbe E:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Nonpharmacological enhancement</span></p>
<p style="top:546.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">of cognitive function in Parkinson&apos;s disease: a systematic review.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Mov</span></p>
<p style="top:555.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt">Disord</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2013,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 28:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">1034</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">1049.</span></p>
<p style="top:564.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">15.</span></p>
<p style="top:564.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Moher D, Liberati A, Tetzlaff J, Altman DG, Grp P:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Preferred Reporting Items</span></p>
<p style="top:573.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">for Systematic Reviews and Meta-Analyses: The PRISMA Statement.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Plos</span></p>
<p style="top:582.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt">Med</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2009,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 6:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">e1000097.</span></p>
<p style="top:591.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">16.</span></p>
<p style="top:591.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Fisher BE, Petzinger GM, Nixon K, Hogg E, Bremmer S, Meshul CK, Jakowec MW:</span></p>
<p style="top:600.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-</span></p>
<p style="top:609.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">phenyl-1,2,3,6-tetrahydropyridine- lesioned mouse basal ganglia.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> J Neurosci</span></p>
<p style="top:618.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt">Res</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2004,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 77:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">378</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">390.</span></p>
<p style="top:627.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">17.</span></p>
<p style="top:627.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Gorton LM, Vuckovic MG, Vertelkina N, Petzinger GM, Jakowec MW, Wood</span></p>
<p style="top:636.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">RI:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Exercise effects on motor and affective behavior and catecholamine</span></p>
<p style="top:645.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">neurochemistry in the MPTP-lesioned mouse.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Behav Brain Res</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2010,</span></p>
<p style="top:654.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">213:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">253</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">262.</span></p>
<p style="top:663.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">18.</span></p>
<p style="top:663.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Tajiri N, Yasuhara T, Shingo T, Kondo A, Yuan W, Kadota T, Wang F, Baba T,</span></p>
<p style="top:672.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Tayra JT, Morimoto T, Jing M, Kikuchi Y, Kuramoto S, Agari T, Miyoshi Y,</span></p>
<p style="top:681.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Fujino H, Obata F, Takeda I, Furuta T, Date I:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Exercise exerts</span></p>
<p style="top:690.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">neuroprotective effects on Parkinson&apos;s disease model of rats.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Brain Res</span></p>
<p style="top:699.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">2010,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 1310:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">200</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">207.</span></p>
<p style="top:708.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">19.</span></p>
<p style="top:708.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Aguiar AS Jr, Araujo AL, Da-Cunha TR, Speck AE, Ignacio ZM, De-Mello N,</span></p>
<p style="top:717.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Prediger RD:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Physical exercise improves motor and short-term social</span></p>
<p style="top:726.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">memory deficits in reserpinized rats.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Brain Res Bull</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2009,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 79:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">452</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">457.</span></p>
<p style="top:34.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Murray</span><span style="font-family:QcghtbAdvTT7329fd89.I,serif;font-size:8.0pt"> et al. Translational Neurodegeneration</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt"> 2014,</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:8.0pt"> 3</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">:5</span></p>
<p style="top:34.0pt;left:492.0pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Page 12 of 13</span></p>
<p style="top:44.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">http://www.translationalneurodegeneration.com/content/3/1/5</span></p>


<p style="top:90.9pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">20.</span></p>
<p style="top:90.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Pothakos K, Kurz MJ, Lau Y-S:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Restorative effect of endurance exercise on</span></p>
<p style="top:99.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">behavioral deficits in the chronic mouse model of Parkinson&apos;s disease</span></p>
<p style="top:108.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">with severe neurodegeneration.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Bmc Neuroscience</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2009,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 10:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">6.</span></p>
<p style="top:118.2pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">21.</span></p>
<p style="top:118.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Goes AT, Souza LC, Filho CB, Del Fabbro L, De Gomes MG, Boeira SP, Jesse</span></p>
<p style="top:127.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">CR:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Neuroprotective effects of swimming training in a mouse model of</span></p>
<p style="top:136.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Parkinson&apos;s disease induced by 6-hydroxydopamine.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Neuroscience</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2014,</span></p>
<p style="top:145.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">256:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">61</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">71.</span></p>
<p style="top:154.5pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">22.</span></p>
<p style="top:154.5pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Baatile J, Langbein WE, Weaver F, Maloney C, Jost MB:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Effect of exercise on</span></p>
<p style="top:163.5pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">perceived quality of life of individuals with Parkinson&apos;s disease.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> J Rehabil</span></p>
<p style="top:172.5pt;left:71.7pt;line-height:7.3pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt">Res Dev</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2000,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 37:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">529</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">534.</span></p>
<p style="top:181.7pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">23.</span></p>
<p style="top:181.7pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Muller T, Muhlack S:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Effect of exercise on reactivity and motor behaviour</span></p>
<p style="top:190.8pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">in patients with Parkinson&apos;s disease.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> J Neurol Neurosurg Psychiatry</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2010,</span></p>
<p style="top:199.8pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">81:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">747</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">753.</span></p>
<p style="top:209.0pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">24.</span></p>
<p style="top:209.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Pompeu JE, dos Santos Mendes FA, da Silva KG, Lobo AM, Oliveira TP,</span></p>
<p style="top:218.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Zomignani AP, Pimentel Piemonte ME:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Effect of Nintendo Wii (TM)-based</span></p>
<p style="top:227.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">motor and cognitive training on activities of daily living in patients with</span></p>
<p style="top:236.1pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Parkinson&apos;s disease: a randomised clinical trial.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Physiotherapy</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2012,</span></p>
<p style="top:245.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">98:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">196</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">204.</span></p>
<p style="top:254.3pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">25.</span></p>
<p style="top:254.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">dos Santos Mendes FA, Pompeu JE, Modenesi Lobo A, Guedes Da Silva K,</span></p>
<p style="top:263.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Oliveira Tde P, Peterson Zomignani A, Pimentel Piemonte ME:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Motor</span></p>
<p style="top:272.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">learning, retention and transfer after virtual-reality-based training in</span></p>
<p style="top:281.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Parkinson&apos;s disease</span><span style="font-family:BdwjnbAdvTTe45e47d2+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">effect of motor and cognitive demands of games:</span></p>
<p style="top:290.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">a longitudinal, controlled clinical study.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Physiotherapy</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2012,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 98:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">217</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">223.</span></p>
<p style="top:299.6pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">26.</span></p>
<p style="top:299.6pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Cruise KE, Bucks RS, Loftus AM, Newton RU, Pegoraro R, Thomas MG:</span></p>
<p style="top:308.6pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Exercise and Parkinson&apos;s: benefits for cognition and quality of life.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Acta</span></p>
<p style="top:317.6pt;left:71.7pt;line-height:7.3pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt">neurologica Scandinavica</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2011,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 123:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">13</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">19.</span></p>
<p style="top:326.9pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">27.</span></p>
<p style="top:326.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Tanaka K, Quadros AC Jr, Santos RF, Stella F, Gobbi LT, Gobbi S:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Benefits of</span></p>
<p style="top:335.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">physical exercise on executive functions in older people with Parkinson&apos;s</span></p>
<p style="top:344.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">disease.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Brain Cogn</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2009,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 69:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">435</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">441.</span></p>
<p style="top:354.2pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">28.</span></p>
<p style="top:354.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Ridgel AL, Kim C-H, Fickes EJ, Muller MD, Alberts JL:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Changes in executive</span></p>
<p style="top:363.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">function after acute bouts of passive cycling in Parkinson&apos;s disease.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> J Aging</span></p>
<p style="top:372.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt">Phys Act</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2011,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 19:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">87</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">98.</span></p>
<p style="top:381.5pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">29.</span></p>
<p style="top:381.5pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">McKee K, Hackney ME:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> The effects of adapted tango on spatial cognition</span></p>
<p style="top:390.5pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">and disease severity in Parkinson&apos;s disease.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> J Mot Behav</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2013,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 45:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">519</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">529.</span></p>
<p style="top:399.7pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">30.</span></p>
<p style="top:399.7pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Goes AT, Souza LC, Filho CB, Del Fabbro L, De Gomes MG, Boeira SP, Jesse</span></p>
<p style="top:408.7pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">CR:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Neuroprotective effects of swimming training in a mouse model of</span></p>
<p style="top:417.8pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Parkinson&apos;s disease induced by 6-hydroxydopamine.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Neuroscience</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2013,</span></p>
<p style="top:426.8pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">256C:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">61</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">71.</span></p>
<p style="top:436.0pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">31.</span></p>
<p style="top:436.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Social</span></p>
<p style="top:445.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">enrichment attenuates nigrostriatal lesioning and reverses motor</span></p>
<p style="top:454.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine</span></p>
<p style="top:463.1pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">(MPTP) mouse model of Parkinson&apos;s disease.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Neurobiol Dis</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2012,</span></p>
<p style="top:472.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">45:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">1051</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">1067.</span></p>
<p style="top:481.3pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">32.</span></p>
<p style="top:481.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J,</span></p>
<p style="top:490.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Schulz KF, Weeks L, Sterne JAC,</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> et al</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> The Cochrane Collaboration&apos;s tool for</span></p>
<p style="top:499.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">assessing risk of bias in randomised trials.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Brit Med J</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2011,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 343:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">889</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">893.</span></p>
<p style="top:508.6pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">33.</span></p>
<p style="top:508.6pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Higgins JPT, Green S (Eds):</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Cochrane Handbook for Systematic Reviews of</span></p>
<p style="top:517.6pt;left:71.7pt;line-height:7.3pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt">Interventions Version 5.1.9 [updated March 2011]. The Cochrane Collaboration.</span></p>
<p style="top:526.6pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">2011. Available from www.cochrane-handbook.org.</span></p>
<p style="top:535.9pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">34.</span></p>
<p style="top:535.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Hoehn MM, Yahr MD:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Parkinsonism: onset, progression and mortality.</span></p>
<p style="top:544.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt">Neurology</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 1967,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 17:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">427</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">442.</span></p>
<p style="top:554.2pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">35.</span></p>
<p style="top:554.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Gerlach M, Riederer P:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Animal models of Parkinson&apos;s disease: an empirical</span></p>
<p style="top:563.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">comparison with the phenomenology of the disease in man.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> J Neural</span></p>
<p style="top:572.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt">Transm</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 1996,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 103:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">987</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">1041.</span></p>
<p style="top:581.5pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">36.</span></p>
<p style="top:581.5pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Jakowec MW, Petzinger GM:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-</span></p>
<p style="top:590.4pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">lesioned model of Parkinson&apos;s disease, with emphasis on mice and</span></p>
<p style="top:599.5pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">nonhuman primates.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Comparative Med</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2004,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 54:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">497</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">513.</span></p>
<p style="top:608.8pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">37.</span></p>
<p style="top:608.8pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Colpaert FC:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Pharmacological characteristics of tremor, rigidity and</span></p>
<p style="top:617.8pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">hypokinesia induced by reserpine in rat.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Neuropharmacology</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 1987,</span></p>
<p style="top:626.7pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">26:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">1431</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">1440.</span></p>
<p style="top:636.0pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">38.</span></p>
<p style="top:636.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Schwarting RK, Huston JP:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> The unilateral 6-hydroxydopamine lesion</span></p>
<p style="top:645.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">model in behavioral brain research. Analysis of functional deficits,</span></p>
<p style="top:654.1pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">recovery and treatments.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Progress in neurobiology</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 1996,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 50:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">275</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">331.</span></p>
<p style="top:663.3pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">39.</span></p>
<p style="top:663.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Schwarting RK, Huston JP:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Unilateral 6-hydroxydopamine lesions of</span></p>
<p style="top:672.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">meso-striatal dopamine neurons and their physiological sequelae.</span></p>
<p style="top:681.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt">Progress in neurobiology</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 1996,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 49:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">215</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">266.</span></p>
<p style="top:690.6pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">40.</span></p>
<p style="top:690.6pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Schwarting RK, Huston JP:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Behavioral and neurochemical dynamics of</span></p>
<p style="top:699.6pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">neurotoxic meso-striatal dopamine lesions.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Neurotoxicology</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 1997,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 18:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">689</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">708.</span></p>
<p style="top:708.9pt;left:56.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">41.</span></p>
<p style="top:708.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Luk KC, Kehm V, Carroll J, Zhang B, O&apos;Brien P, Trojanowski JQ, Lee VMY:</span></p>
<p style="top:717.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Pathological alpha-Synuclein Transmission Initiates Parkinson-like</span></p>
<p style="top:726.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Neurodegeneration in Nontransgenic Mice.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Science</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2012,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 338:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">949</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">953.</span></p>
<p style="top:90.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">42.</span></p>
<p style="top:90.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Horvath J, Herrmann FR, Burkhard PR, Bouras C, Kovari E:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Neuropathology</span></p>
<p style="top:99.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">of dementia in a large cohort of patients with Parkinson&apos;s disease.</span></p>
<p style="top:108.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt">Parkinsonism Relat Disord</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2013,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 19:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">864</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">868. discussion 864.</span></p>
<p style="top:117.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">43.</span></p>
<p style="top:117.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Kim S-E, Ko I-G, Shin M-S, Kim C-J, Jin B-K, Hong H-P, Jee Y-S:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Treadmill</span></p>
<p style="top:126.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">exercise and wheel exercise enhance expressions of neutrophic factors in</span></p>
<p style="top:135.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">the hippocampus of lipopolysaccharide-injected rats.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Neurosci Lett</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2013,</span></p>
<p style="top:144.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">538:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">54</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">59.</span></p>
<p style="top:153.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">44.</span></p>
<p style="top:153.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Zigmond MJ, Cameron JL, Hoffer BJ, Smeyne RJ:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Neurorestoration by</span></p>
<p style="top:162.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">physical exercise: moving forward.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Parkinsonism Relat Disord</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2012,</span></p>
<p style="top:171.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">18</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">(Supplement 1)</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">S147</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">S150.</span></p>
<p style="top:180.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">45.</span></p>
<p style="top:180.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Fisher BE, Li Q, Nacca A, Salem GJ, Song J, Yip J, Hui JS, Jakowec MW,</span></p>
<p style="top:189.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Petzinger GM:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Treadmill exercise elevates striatal dopamine D2 receptor</span></p>
<p style="top:198.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">binding potential in patients with early Parkinson&apos;s disease.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Neuroreport</span></p>
<p style="top:207.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">2013,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 24:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">509</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">514.</span></p>
<p style="top:216.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">46.</span></p>
<p style="top:216.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Higginson CI, King DS, Levine D, Wheelock VL, Khamphay NO, Sigvardt KA:</span></p>
<p style="top:225.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">The relationship between executive function and verbal memory in</span></p>
<p style="top:234.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Parkinson&apos;s disease.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Brain Cogn</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2003,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 52:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">343</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">352.</span></p>
<p style="top:243.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">47.</span></p>
<p style="top:243.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC,</span></p>
<p style="top:252.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky</span></p>
<p style="top:261.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">J, Rogriguez-Oroz MC, Burn DJ, Barker RA, Emre M:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Diagnostic criteria for</span></p>
<p style="top:270.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">mild cognitive impairment in Parkinson&apos;s disease: Movement Disorder</span></p>
<p style="top:279.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Society Task Force guidelines.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Mov Disord</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2012,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 27:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">349</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">356.</span></p>
<p style="top:288.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">48.</span></p>
<p style="top:288.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Kudlicka A, Clare L, Hindle JV:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Executive functions in Parkinson&apos;s disease:</span></p>
<p style="top:297.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Systematic review and meta-analysis.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Mov Disord</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2011,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 26:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">2305</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">2315.</span></p>
<p style="top:306.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">49.</span></p>
<p style="top:306.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Lezak MD:</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Neuropsychological assessment.</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 3rd edition. New York: Oxford</span></p>
<p style="top:315.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">University Press; 1995.</span></p>
<p style="top:324.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">50.</span></p>
<p style="top:324.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Kramer AF, Hahn S, Cohen NJ, Banich MT, McAuley E, Harrison CR, Chason J,</span></p>
<p style="top:333.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Vakil E, Bardell L, Boileau RA, Colcombe A:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Ageing, fitness and</span></p>
<p style="top:342.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">neurocognitive function.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Nature</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 1999,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 400:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">418</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">419.</span></p>
<p style="top:351.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">51.</span></p>
<p style="top:351.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Petzinger GM, Walsh JP, Akopian G, Hogg E, Abernathy A, Arevalo P,</span></p>
<p style="top:360.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Turnquist P, Vuckovic M, Fisher BE, Togasaki DM, Jakowec MW:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Effects of</span></p>
<p style="top:369.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">treadmill exercise on dopaminergic transmission in the 1-methyl-4-</span></p>
<p style="top:378.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia</span></p>
<p style="top:387.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">injury.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> J Neurosci</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2007,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 27:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">5291</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">5300.</span></p>
<p style="top:396.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">52.</span></p>
<p style="top:396.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Vuckovic MG, Li QZ, Fisher B, Nacca A, Leahy RM, Walsh JP, Mukherjee J,</span></p>
<p style="top:405.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Williams C, Jakowec MW, Petzinger GM:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Exercise elevates dopamine D2</span></p>
<p style="top:414.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">receptor in a mouse model of Parkinson&apos;s disease: in Vivo imaging with</span></p>
<p style="top:423.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">[F-18]Fallypride.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Mov Disord</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2010,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 25:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">2777</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">2784.</span></p>
<p style="top:432.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">53.</span></p>
<p style="top:432.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">de Melo Coelho FG, Gobbi S, Almeida Andreatto CA, Corazza DI, Pedroso</span></p>
<p style="top:441.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">RV, Santos-Galduroz RF:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Physical exercise modulates peripheral levels of</span></p>
<p style="top:450.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">brain-derived neurotrophic factor (BDNF): a systematic review of</span></p>
<p style="top:459.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">experimental studies in the elderly.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Arch Gerontol Geriatr</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2013,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 56:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">10</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">15.</span></p>
<p style="top:468.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">54.</span></p>
<p style="top:468.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Sartorius A, Hellweg R, Litzke J, Vogt M, Dormann C, Vollmayr B,</span></p>
<p style="top:477.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Danker-Hopfe H, Gass P:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Correlations and discrepancies between</span></p>
<p style="top:486.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">serum and brain tissue levels of neurotrophins after electroconvulsive</span></p>
<p style="top:495.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">treatment in rats.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Pharmacopsychiatry</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2009,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 42:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">270</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">276.</span></p>
<p style="top:504.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">55.</span></p>
<p style="top:504.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Chang YK, Labban JD, Gapin JI, Etnier JL:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> The effects of acute exercise on</span></p>
<p style="top:513.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">cognitive performance: a meta-analysis.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Brain Res</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2012,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 1453:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">87</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">101.</span></p>
<p style="top:522.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">56.</span></p>
<p style="top:522.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Langlois F, Vu TTM, Chasse K, Dupuis G, Kergoat MJ, Bherer L:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> Benefits of</span></p>
<p style="top:531.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">physical exercise training on cognition and quality of life in frail older</span></p>
<p style="top:540.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">adults.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> J Gerontol B-Psychol</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2013,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 68:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">400</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">404.</span></p>
<p style="top:549.9pt;left:304.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">57.</span></p>
<p style="top:549.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">Gates N, Fiatarone Singh MA, Sachdev PS, Valenzuela M:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> The effect of</span></p>
<p style="top:558.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">exercise training on cognitive function in older adults with mild</span></p>
<p style="top:567.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">cognitive impairment: a meta-analysis of randomized controlled trials.</span></p>
<p style="top:576.9pt;left:319.7pt;line-height:7.3pt"><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt">Am J Geriatr Psychiatry</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> 2013,</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 21:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">1086</span><span style="font-family:NggjhpAdvTTb5929f4c+20,serif;font-size:7.3pt">&#x2013;</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">1097.</span></p>
<p style="top:596.2pt;left:310.2pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">doi:10.1186/2047-9158-3-5</span></p>
<p style="top:604.7pt;left:310.2pt;line-height:7.3pt"><span style="font-family:NdtjypAdvTT99c4c969,serif;font-size:7.3pt">Cite this article as:</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt"> Murray</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> et al.</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">:</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> The effects of exercise on cognition in</span></p>
<p style="top:613.2pt;left:310.2pt;line-height:7.3pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">Parkinson</span><span style="font-family:BdwjnbAdvTTe45e47d2+20,serif;font-size:7.3pt">&#x2019;</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt">s disease: a systematic review.</span><span style="font-family:BgmkmfAdvTT1b53b5fb.I,serif;font-size:7.3pt"> Translational Neurodegeneration</span></p>
<p style="top:621.7pt;left:310.2pt;line-height:7.3pt"><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">2014</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:7.3pt"> 3</span><span style="font-family:RnsncnAdvTTb5929f4c,serif;font-size:7.3pt">:5.</span></p>
<p style="top:34.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Murray</span><span style="font-family:QcghtbAdvTT7329fd89.I,serif;font-size:8.0pt"> et al. Translational Neurodegeneration</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt"> 2014,</span><span style="font-family:VnggyhAdvTTaf7f9f4f.B,serif;font-size:8.0pt"> 3</span><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">:5</span></p>
<p style="top:34.0pt;left:492.0pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">Page 13 of 13</span></p>
<p style="top:44.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:SrgcwyAdvTTe45e47d2,serif;font-size:8.0pt">http://www.translationalneurodegeneration.com/content/3/1/5</span></p>

</div>
